POPULARITY
Categories
“I will always tell the American people the truth. Pesticides and herbicides are toxic by design, engineered to kill living organisms” writes Robert F. Kennedy Jr., Secretary of the HHS. “Unfortunately, our agricultural system depends heavily on these chemicals… If these inputs disappeared overnight, crop yields would fall, food prices would surge, and America would experience a massive loss of farms… The consequences would be disastrous.” MAHA is split over Kennedy's statement explaining President Trump's recent support for Bayer and their product Roundup (originally from Monsanto). Glyphosate, the active ingredient in Roundup, is an herbicide that has been linked to non-Hodgkin's lymphoma, was labeled “probably carcinogenic” by the International Agency for Research on Cancer, and is the subject of thousands of lawsuits. It is the most-used weedkiller in history. Remi Adeleke is a former Navy SEAL, filmmaker, and author. Born in Nigeria and raised in the Bronx, his life journey from poverty and criminal activity to military service and filmmaking is detailed in his memoir Transformed. Follow at https://x.com/RemiAdeleke⠀Michael Malice is the host of the podcast YOUR WELCOME. He is the author of multiple books including The White Pill: A Tale of Good and Evil, and coauthor of two New York Times best sellers. Follow at https://x.com/michaelmalice⠀Dr. Sina McCullough is a nutrition scientist and best-selling author. She holds a PhD in Nutrition and a BS in Neurobiology, Physiology and Behavior from the University of California, Davis. Learn more at https://www.drsinamccullough.com⠀Zen Honeycutt is the founding Executive Director of Moms Across America and author of UNSTOPPABLE. Learn more at https://momsacrossamerica.com 「 SUPPORT OUR SPONSORS 」 • AUGUSTA PRECIOUS METALS – Thousands of Americans are moving portions of their retirement into physical gold & silver. Learn more in this 3-minute report from our friends at Augusta Precious Metals: https://drdrew.com/gold or text DREW to 35052 • FATTY15 – The future of essential fatty acids is here! Strengthen your cells against age-related breakdown with Fatty15. Get 15% off a 90-day Starter Kit Subscription at https://drdrew.com/fatty15 • PALEOVALLEY - "Paleovalley has a wide variety of extraordinary products that are both healthful and delicious,” says Dr. Drew. "I am a huge fan of this brand and know you'll love it too!” Get 15% off your first order at https://drdrew.com/paleovalley • THE WELLNESS COMPANY - Counteract harmful spike proteins with TWC's Signature Series Spike Support Formula containing nattokinase and selenium. Learn more about TWC's supplements at https://twc.health/drew 「 ABOUT THE SHOW 」 This show is for entertainment and/or informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment. Executive Producers • Kaleb Nation - https://kalebnation.com • Susan Pinsky - https://x.com/firstladyoflove Content Producer • Emily Barsh - https://x.com/emilytvproducer Hosted By • Dr. Drew Pinsky - https://x.com/drdrew Learn more about your ad choices. Visit megaphone.fm/adchoices
In episode 2018, Jack and Miles are joined by comedian and host of Abolish Everything, Chandler Dean, to discuss… Noem’s TERRIBLE Week, RFK Jr vs Dunkin, You Can Blame Big Oil and Big Golf For Daylight Saving Time and more! Tillis to Noem: "Those are bad decisions made in the heat of the moment, not unlike what happened in Minneapolis." Rep. Kamlager-Dove enters articles in the congressional record with headlines like, "Lewandowski taking out trash at Noem's DC home" and "ICE Barbie's mile high private chamber with alleged lover exposed" Noem Gets Grilled Over Government Contracts RFK Jr vs Dunkin RFK Jr. took aim at Dunkin'. Mass. residents threatened revolts Your favorite iced summer coffee could contain 46 teaspoons of sugar — the same as drinking 5 cans of Coke British Columbia Will Change Clocks on Sunday for the Last Time 7 Things to Know About Daylight Saving Time The dark side of daylight saving time B.C.'s premier is celebrating the move to permanent daylight time. Others aren't so sure Bill To Make Daylight Saving Time Permanent Stalls In Congress Again What Happened the Last Time the U.S. Tried to Make Daylight Saving Time Permanent? The Real Reason Why Daylight Saving Time Is a Thing The stakeholders of daylight saving time Golf industry tees up fight to keep daylight saving time The business of Daylight Saving Time, from golf to oil 9 Things You Probably Don't Know About Daylight Saving Time The Reasoning Behind Changing Daylight-Saving Is permanent daylight saving time a good idea? Lobbyists, lawmakers and sleep experts are split. What would ‘half-daylight saving time’ look like? LISTEN: Mesa Mesa by YuufSee omnystudio.com/listener for privacy information.
Health Affairs' Jeff Byers welcomes Senior Editor Margaret Winchester to the pod to discuss Trump's recent State of the Union Address and unpacking its health care and health policy talking points, including most-favored nation drug pricing, health savings accounts, and if there's a path toward codification for either.On March 24th, join us for our upcoming Insider exclusive event focusing on pharmacy benefit manager reform with Harvard Medical School's Benjamin Rome.Related Articles:National Health Care Spending Increased 7.2 Percent In 2024 As Utilization Remained Elevated (Health Affairs)Trump's State of the Union trumpets healthcare greatest hits, but no new policies (Healthcare Dive)
In this episode, Limo Cherian, Rebecca Schaefer, and Clarita Sullivan break down the Department of Health and Human Services' (HHS) recent Request for Information on Accelerating the Adoption and Use of Artificial Intelligence (AI) as part of Clinical Care. They discuss why HHS is seeking input from both AI innovators and those facing adoption barriers, what the agency hopes to achieve with this feedback, and how it could shape future regulations, reimbursement policies, and research priorities. If you are an in-house attorney navigating the evolving AI landscape, tune in for practical insights on regulatory trends, federal priorities, and what's next for AI in healthcare. As mentioned in the episode, you can view HHS's consolidated responses and copies of schedules here.
A suspected U.S. exploit kit shows up in global iOS attacks. Facebook goes down briefly worldwide. A critical help-desk flaw enables remote code execution. Juniper PTX routers face a major bug. LastPass warns of phishing. Telegram becomes a cybercrime marketplace. Healthcare groups fight relaxed IT rules. A stolen Gemini API key runs up massive bills. CISA's CIO departs. Our guest is Brian Long, CEO and Co-Founder of Adaptive Security, discussing how AI is reshaping social engineering. The problem of posthumous profiles. CyberWire Guest Today on our Industry Voices segment we are joined by Brian Long, CEO and Co-Founder of Adaptive Security, discussing how AI is reshaping social engineering. If you want to hear the full conversation, listen to it here. Selected Reading Possible U.S.-developed exploits linked to first known ‘mass' iOS attack (CyberScoop) Facebook accounts unavailable in worldwide outage (Bleeping Computer) Critical FreeScout Vulnerability Leads to Full Server Compromise (SecurityWeek) Juniper PTX Routers at Risk, Critical Takeover Flaw Disclosed (BankInfo Security) LastPass Warns of New Phishing Campaign (SecurityWeek) Telegram Increasingly Used to Sell Access, Malware and Stolen Logs Hackread) Groups Push Back on HHS' Proposed Health IT Rollbacks (BankInfo Security) Dev stunned by $82K Gemini API key bill after theft (The Register) CISA CIO Robert Costello exits agency (CyberScoop) Calls for Global Digital Estate Standard as Posthumous Deepfake Fraud Risk Grows (Infosecurity Magazine) Share your feedback. What do you think about CyberWire Daily? Please take a few minutes to share your thoughts with us by completing our brief listener survey. Thank you for helping us continue to improve our show. Want to hear your company in the show? N2K CyberWire helps you reach the industry's most influential leaders and operators, while building visibility, authority, and connectivity across the cybersecurity community. Learn more at sponsor.thecyberwire.com. The CyberWire is a production of N2K Networks, your source for strategic workforce intelligence. © N2K Networks, Inc. Learn more about your ad choices. Visit megaphone.fm/adchoices
Hoppe Hoppe Scheitern - Der Eltern Real Talk mit Evelyn Weigert
Medizin-Influencerin, Autorin und aktuell schwanger mit ihrem dritten Kind – Gästin Dr. Julia Fischer bringt jede Menge Expertise mit in den Talk mit Evelyn. Da sie seit vielen Jahren befreundet sind, kommen aber auch persönliche Anekdoten nicht zu kurz. Julias Geburten (Spoiler: Hypnobirthing als Gamechanger!) und ihre Sicht auf die Themen Ernährung und Nahrungsergänzungsmittel stehen im Fokus. Sind Supplements nötig oder nicht? Wenn ja, welche? Und was ist mit Proteinen, wenn wir möglichst lang fit und gesund bleiben wollen? Außerdem: Zucker bleibt Zucker, Social-Media-Rezepte sind nicht immer genießbar, Overthinking war gestern, denn 80/20 reicht völlig. Was diese Regel besagt? Zu hören in dieser Folge. Viel Spaß! Hier gibt es mehr von Dr. Julia Fischer: https://www.instagram.com/dr.juliafischer/ Du möchtest mehr über unsere Werbepartner erfahren? Hier findest du alle Infos & Rabatte: https://linktr.ee/AllemeineEltern Du möchtest Werbung in diesem Podcast schalten? Dann erfahre hier mehr über die Werbemöglichkeiten bei Seven.One Audio: https://www.seven.one/portfolio/sevenone-audio
Paul Offit, MD, director of the Vaccine Education Center, an attending physician in the Division of Infectious Diseases at Children's Hospital of Philadelphia, and the author of Autism's False Prophets (Columbia University Press, 2008) and Tell Me When It's Over: An Insider's Guide to Deciphering COVID Myths and Navigating Our Post-Pandemic World (National Geographic, 2024), talks about the changes to vaccine recommendations and conceptions of public health in the current HHS. Photo by Pablo la Rosa, 10 April 2025, Wikimedia Commons.
March 3, 2026: Your daily rundown of health and wellness news, in under 5 minutes. Today's top stories: Temple raises $54M for temple-worn wearable continuously measuring brain blood flow to quantify focus, fatigue, and cognitive resilience in real time MyFitnessPal acquires AI-native Cal AI with $40M+ in sales, deepening push into digital nutrition tracking across 280M registered members HHS plans to reclassify 14 peptides including BPC-157 and CJC-1295 back to Category 1, enabling licensed compounding pharmacies to produce them with prescription More from Fitt: Fitt Insider breaks down the convergence of fitness, wellness, and healthcare — and what it means for business, culture, and capital. Subscribe to our newsletter → insider.fitt.co/subscribe Work with our recruiting firm → https://talent.fitt.co/ Follow us on Instagram → https://www.instagram.com/fittinsider/ Follow us on LinkedIn → linkedin.com/company/fittinsider Reach out → insider@fitt.co
Jay Nakashima, President at eHealth Exchange, discusses in this video interview some recent hot developments in health data exchange, and how he expects it to expand in the future.HHS's TEFCA project has been in force for some time, while the CMS-Aligned Network is new and has created confusion in the industry about the relatinship between them (Note: Steven Posnack has a great article that works to clear this up). eHealth Exchange is a designated QHIN under TEFCA and plans to implement the criteria necessary to become a CMS-Aligned Network as well. Nakashima recommends that anyone who has started to work with TEFCA continue to do so.He calls TEFCA "prescriptive" and thinks that more varied options will become available.Learn more about eHealth Exchange: https://ehealthexchange.org/Healthcare IT Community: https://www.healthcareittoday.com/
The Middle East faces a major geopolitical shift following a joint U.S. and Israeli operation in Iran that resulted in the death of Supreme Leader Ayatollah Ali Khamenei and several top commanders. President Trump ordered the strike with the goal of "giving the country back to the Iranian people," sparking debate in Washington over executive authority and the War Powers Act. Texas Republican Congressman Pat Fallon, a member of the Armed Services and Intelligence Committees, joins the Rundown to discuss the strategic implications of the attack, and the risk of retaliation at home. With 30 million Americans living with a rare disease, is the traditional "blockbuster" drug model failing the approximately one in 11 people who need specialized care? Judy Stecker, founder of Wheeler's Warriors and former HHS official, joins us to discuss a historic shift at the FDA. From the groundbreaking use of genome editing to treat metabolic diseases to the emotional journey of her son Wheeler, Stecker explains how she believes the science of "genetic patches" has finally outpaced our regulatory system. Plus, commentary by Senior Fellow at the Lexington Institute, Dr. Rebecca Grant. Learn more about your ad choices. Visit podcastchoices.com/adchoices
On this episode:CONFLICT WITH IRANI can't pretend to know how good or bad an idea our conflict with Iran is. I can tell you the American military is probably the most impressive institution in the world right now.BIRTHRATE FACT I learned recently that a large portion of our declining birth rates come from a cratering TEENAGED pregnancy rate and a falling UNWED pregnancy rate.CLEAN YOUR OWN HOUSEFolks on the Right — especially Christians — should be opposing the president's appointment of Casey means at HHS. She's literally a Wiccan witch.MUCH MUCH more
Ever wondered who really decides what America should eat—and how those choices land on your tray at school, your hospital menu, or your family's grocery list? We take you behind the scenes of the U.S. dietary guidelines, charting the history from the low-fat era and the iconic food pyramid to today's more pattern-based approach. Along the way, we explore the messy overlap of science, policy, economics, and everyday life, and why sweeping changes rarely make it into federal guidance even when headlines suggest otherwise.We break down what the guidelines actually are—a population-level tool shaped by USDA and HHS. You'll hear how evidence evolves, how advisory committees weigh it, and where industry and agricultural interests push at the edges. Just as important, we zoom in on the realities that drive eating habits: access to fresh food, time to cook, stable housing, kitchen equipment, and tight budgets. It's one thing to recommend more vegetables and fish; it's another to make those options affordable and available in every zip code.By reframing the guidelines as a floor instead of a ceiling, we point to what matters most for public health today: fewer sugar-sweetened beverages, less ultra-processed food, smarter portions, and more whole foods. We also preview what's coming next in our series—deep dives into saturated fat, added sugars, protein needs, ultra-processed foods, and alcohol—assessing where the evidence is strong and where it's still emerging. If you've ever asked, “Are these rules outdated or influenced?” or “Should I follow them at all?”, this conversation gives you the context to decide—and the language to advocate for better access and smarter policy in your community.If you found this useful, follow the show, share it with a friend, and leave a quick review telling us what part of nutrition policy you want us to tackle next.Send us a message with this link, we would love to hear from you. Standard message rates may apply.Support the showProduction and Content: Edward Delesky, MD, DABOM & Nicole Aruffo, RN Artwork Rebrand and Avatars: Vantage Design Works (Vanessa Jones) Website: https://www.vantagedesignworks.com/ Instagram: https://www.instagram.com/vantagedesignworks?igsh=aHRuOW93dmxuOG9m&utm_source=qr Original Artwork Concept: Olivia Pawlowski
MAHA may be coming to an end… sooner rather than later. And much like the quote “The saddest thing about betrayal is that it never comes from your enemies.” The destruction is coming from the leader, the founder of MAHA, RFK Jr. himself. He rode MAHA into the White House and earned himself the title of Secretary of HHS. However, his crusade to end the trend of captured agencies, to push back against Big Pharma and to take on Big Ag is turning out to be more of myth than MAHA.This week, President Trump signed an executive order titled “Promoting the National Defense by Ensuring and Adequate Supply of Elemental Phosphorus and Glyphosate - Based Herbicides." Right off the bat, you can deduce that if the government says something is for national defense it's probably poppycock. What this order does has nothing to do with national security. It promotes domestic production of glyphosate while shielding the manufacturer from liability for any damage it may cause.***Thanks for listening to Overnight Opinions, a recurring news show on topics the mainstream media isn't telling you. Here you'll get current events blended with spicy commentary directed at our elected leaders. You can check out Ladies Love Politics website to read a transcript/references of this episode at www.ladieslovepolitics.com. Be sure to follow the Ladies Love Politics channel on TikTok, Instagram, YouTube, Truth Social, Brighteon Social, Threads, and Twitter. Content also available on Apple Podcasts, Google Podcasts, Spotify, and wherever else you stream podcasts. Background Music Credit:Music: Hang for Days - Silent Partner https://youtu.be/A41A0XeU2ds
The Middle East faces a major geopolitical shift following a joint U.S. and Israeli operation in Iran that resulted in the death of Supreme Leader Ayatollah Ali Khamenei and several top commanders. President Trump ordered the strike with the goal of "giving the country back to the Iranian people," sparking debate in Washington over executive authority and the War Powers Act. Texas Republican Congressman Pat Fallon, a member of the Armed Services and Intelligence Committees, joins the Rundown to discuss the strategic implications of the attack, and the risk of retaliation at home. With 30 million Americans living with a rare disease, is the traditional "blockbuster" drug model failing the approximately one in 11 people who need specialized care? Judy Stecker, founder of Wheeler's Warriors and former HHS official, joins us to discuss a historic shift at the FDA. From the groundbreaking use of genome editing to treat metabolic diseases to the emotional journey of her son Wheeler, Stecker explains how she believes the science of "genetic patches" has finally outpaced our regulatory system. Plus, commentary by Senior Fellow at the Lexington Institute, Dr. Rebecca Grant. Learn more about your ad choices. Visit podcastchoices.com/adchoices
The Middle East faces a major geopolitical shift following a joint U.S. and Israeli operation in Iran that resulted in the death of Supreme Leader Ayatollah Ali Khamenei and several top commanders. President Trump ordered the strike with the goal of "giving the country back to the Iranian people," sparking debate in Washington over executive authority and the War Powers Act. Texas Republican Congressman Pat Fallon, a member of the Armed Services and Intelligence Committees, joins the Rundown to discuss the strategic implications of the attack, and the risk of retaliation at home. With 30 million Americans living with a rare disease, is the traditional "blockbuster" drug model failing the approximately one in 11 people who need specialized care? Judy Stecker, founder of Wheeler's Warriors and former HHS official, joins us to discuss a historic shift at the FDA. From the groundbreaking use of genome editing to treat metabolic diseases to the emotional journey of her son Wheeler, Stecker explains how she believes the science of "genetic patches" has finally outpaced our regulatory system. Plus, commentary by Senior Fellow at the Lexington Institute, Dr. Rebecca Grant. Learn more about your ad choices. Visit podcastchoices.com/adchoices
In his weekly clinical update, Dr. Griffin and Vincent Racaniello discuss several states and the governor of Pennsylvania suing HHS over changes in the childhood vaccination schedule, the vaccine derived type 2 poliovirus outbreak in Pakistan and implications for the global withdrawal of the oral poliovirus vaccine, and the outbreak of Candida, then Dr. Griffin deep dives into recent statistics RSV, influenza and SARS-CoV-2 infections, the Wasterwater Scan dashboard, Johns Hopkins measles tracker, where to find PEMGARDA, how to access and pay for Paxlovid, when to use steroids for treating influenza, long COVID treatment center, where to go for answers to your long COVID questions, and contacting your federal government representative to stop the assault on science and biomedical research. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode States vs RFK Jr and Bhattacharya: changes to the childhood vaccine schedule (Office of the Attorney General, California) Surgeon General Nominee Sidesteps Questions on Vaccines at Senate Hearing (NY Times) Unqualified failure in polio vaccine policy left thousands of kids paralyzed (Science) Clinical and Epidemiological Investigation of Vaccine-Derived Poliovirus Type 2 Outbreak in Pakistan During 2019–2021 (CID) Inactivated Polio Vaccine Must Be an Essential Part of Polio Eradication (CID) Wastewater for Candida auris: Wastewater (WasterWater Scan) Wastewater for measles (WasterWater Scan) Measles cases and outbreaks (CDC Rubeola) Big outbreak, bright lights…Measles Dashboard (South Carolina Department of Public Health) Utah Measles Dashboard (Utah Department of Health and Human Services) Tracking Measles Cases in the U.S. (Johns Hopkins) Measles vaccine recommendations from NYP (jpg) Weekly measles and rubella monitoring (Government of Canada) Measles (WHO) Get the FACTS about measles (NY State Department of Health) Measles (CDC Measles (Rubeola)) Measles vaccine (CDC Measles (Rubeola)) Presumptive evidence of measles immunity (CDC) Contraindications and precautions to measles vaccination (CDC) Adverse events associated with childhood vaccines: evidence bearing on causality (NLM) Measles Vaccination: Know the Facts (ISDA: Infectious Diseases Society of America) Deaths following vaccination: what does the evidence show (Vaccine) Influenza: Waste water scan for 11 pathogens (WastewaterSCan) US respiratory virus activity (CDC Respiratory Illnesses) Respiratory virus activity levels (CDC Respiratory Illnesses) Weekly surveillance report: cliff notes (CDC FluView) OPTION 2: XOFLUZA $50 Cash Pay Option (xofluza) RSV: Waste water scan for 11 pathogens (WastewaterSCan) Respiratory Diseases (Yale School of Public Health) US respiratory virus activity (CDC Respiratory Illnesses) RSV-Network (CDC Respiratory Syncytial virus Infection) Vaccines for Adults (CDC: Respiratory Syncytial Virus Infection (RSV)) Economic Analysis of Protein Subunit and mRNA RSV Vaccination in Adults aged 50-59 Years (CDC: ACIP) Respiratory Diseases (Yale School of Public Health) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 deaths (CDC) Respiratory Illnesses Data Channel (CDC: Respiratory Illnesses) COVID-19 national and regional trends (CDC) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) COVID-19 vaccination status during pregnancy and preeclampsia risk: the pandemic-era cohort of the INTERCOVID consortium (eClinical Medicine) Where to get pemgarda (Pemgarda) EUAfor the pre-exposure prophylaxis of COVID-19 (INVIYD) Infusion center (Prime Fusions) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Drug interaction checker (University of Liverpool) Help your eligible patients access PAXLOVID with the PAXCESS Patient Support Program (Pfizer Pro) Understanding Coverage Options (PAXCESS) Infectious Disease Society guidelines for treatment and management (ID Society) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) Use of corticosteroids in influenza-associated acute respiratory distress syndrome and severe pneumonia: a systemic review and meta-analysis(Scientific Reports) What to do when sick with a respiratory virus (CDC) Managing healthcare staffing shortages (CDC) Anticoagulationguidelines (hematology.org) Daniel Griffin's evidence based medical practices for long COVID (OFID) Long COVID hotline (Columbia : Columbia University Irving Medical Center) The answers: Long COVID Reaching out to US house representative Letters read on TWiV 1300 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene Ramsey. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv Content in this podcast should not be construed as medical advice.
On this episode of The Federalist Radio Hour, John Hart, CEO of government transparency nonprofit Open the Books, joins Federalist Senior Elections Correspondent Matt Kittle to discuss ballooning Medicaid fraud in states like Pennsylvania and analyze the fight to expose the loopholes that lead to taxpayer-funded waste.Read more about Open the Book's role in exposing Medicaid fraud here and here.The Federalist Foundation is a nonprofit, and we depend entirely on our listeners and readers — not corporations. If you value fearless, independent journalism, please consider a tax-deductible gift today at TheFederalist.com/donate. Your support keeps us going.
President Trump highlights healthcare reforms in this year's State of the Union. Fifteen states sue HHS over changes to the federal childhood vaccine schedule. And Medicare Advantage margins outperform other lines of business in 2024. Listen to the latest episode of The Gist Healthcare Podcast. Hosted on Acast. See acast.com/privacy for more information.
Health Affairs' Jeff Byers welcomes Brown University's Andrew Ryan to the pod to discuss his recent Forefront article that explores whether value-based payment and managed care can lead to addressing the core drivers of spending.Related Links:Value-Based Payment And Managed Care Will Not Solve The Affordability Crisis (Health Affairs Forefront)“All I Do Is Win”: Why Beating Benchmarks Doesn't Mean That ACOs Are Reducing Costs (Health Affairs Forefront)
Pink Sheet Executive Editor Derrick Gingery, Editor-in-Chief Nielsen Hobbs and special guest Dave Wallace, executive editor of Generics Bulletin, discuss the generic industry's future direction and priorities (:27) and the impact of recent policy moves on the biosimilar industry (12:28) following their trade association's annual meeting, as well as US Food and Drug Administration Commissioner Martin Makary's comment on compassionate use and the concern it may have caused industry (20:23). More On These Topics From The Pink Sheet The State Of The Off-Patent Union: AAM's Murphy Sets Out US Achievements And Obstacles: https://insights.citeline.com/pink-sheet/biosimilars-and-generics/the-state-of-the-off-patent-union-aams-murphy-sets-out-achievements-and-obstacles-in-us-IHJH2CZBX5GGTI6UJQVE2WO2G4/ ‘Biology Is Dirty': HHS's Principal Deputy Counsel On How Biosimilar Firms Can Help US FDA: https://insights.citeline.com/pink-sheet/biosimilars-and-generics/biosimilars/biology-is-dirty-hhss-principal-deputy-counsel-on-how-biosimilar-firms-can-help-us-fda-2GEAUSXNMRCYNIXPS7P6IAYESE/ Makary's Compassionate Use Comments, Later Clarified, Still May Startle Industry: https://insights.citeline.com/pink-sheet/rare-diseases/makarys-compassionate-use-comments-later-clarified-still-may-startle-industry-XPBVZ6MH7FC7JKP2XEL4ZESWSE/
This week in the Breakroom, Anthony Livshen and Katie Waldo join Erin Fuller to discuss HHS's release of the largest public dataset of Medicaid provider spending data in department history; breaking down what the dataset includes, its analytical value and limitations, and how the release may influence the broader congressional and administrative focus on fraud, waste, and abuse in healthcare programs.
Dr Mary Talley Bowden joins The Jeff Dornik Show to break down her legal battle against the Texas Medical Board after it issued a public reprimand for her good faith effort to administer Ivermectin to a dying COVID patient under a court order. The Board ignored medical expert testimony, disregarded due process, and punished her despite her reliance on judicial authority and legal counsel. Attorney General Ken Paxton has now intervened to defend Dr Mary Talley Bowden's constitutional rights and refuse representation of the Texas Medical Board in her case. The discussion also examines RFK Jr's first year leading HHS, the reality of MAHA, and the continued presence of COVID shots on the market amid reports of disease, disability, and death without accountability.SPONSORSupermassive Black Coffee is crafted from organic, gourmet beans fire-roasted in an antique Victorian-era roaster, delivering the rich, smooth, non-acidic taste that reminds you this is how coffee was always meant to be. Use code JEFF50 for 50% off your first order. https://supermassiveblackcoffee.com/?ref=JEFFFollow Dr Mary Talley Bowden on Pickax - https://pickax.com/mdbreatheFollow Jeff Dornik on Pickax - https://pickax.com/jeffdornikTune into The Jeff Dornik Show LIVE daily at 1pm ET on Rumble. Subscribe on Rumble and never miss a show. https://rumble.com/c/jeffdornikPickax is officially live, and we are building what Big Tech refused to build, a platform where creators own their voice, their audience, and their future without algorithms manipulating reach or silencing truth. Download Pickax today in the Google Play Store and Apple App Store and join a movement where technology serves people, freedom, and real human connection. https://pickax.com/?referralCode=y7wxvwq&refSource=copy
Find out about the best food for gut health that acts as a powerful immunity booster and even contains natural stem cells. No supplement or superfood comes close to this healthiest food on Earth! Can you guess what it is?
The Education Department is handing off more work to other federal agencies, as part of plans to dismantle its operations. It's sharing some of its duties with the departments of State Department and the Department of Health and Human Services. Education transferred some of its employees to the Labor Department last year. But so far, no employees have been detailed to State or HHS. Federal News Network's Jory Heckman has more. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Hoppe Hoppe Scheitern - Der Eltern Real Talk mit Evelyn Weigert
200 Folgen „Alle meine Eltern“ – und Evelyn hat sich zum Jubiläum natürlich wieder einmal ihren Lieblingsgast geschnappt: Ehemann Alex. Die beiden starten ihren Talk direkt intim, denn es geht um Schnippischnippi alias „Ball Wars“. Alex erzählt von seiner Vasektomie – keine Schnitte, kaum Schmerzen, alles wie vorher. Vorerst also Schluss mit Kinderplanung. Und ganz nebenbei ein klares Statement: Verhütung ist nicht allein Frauensache. Außerdem wird übers Rülpsen gesprochen (für Evelyn Freiheit, eklig für Alex, extrem lustig für ihre Kinder) sowie über fehlende Paarzeit, Sleep Divorce und Co-Sleeping – und darüber, dass Streit selten wirklich an Socken oder Schuhen liegt, sondern meistens an schlichter Überforderung. Eifersucht? Fehlanzeige. Trotz Künstlerleben gibt es viel Vertrauen und wenig Drama. Dazu: Namen für Jungs, Angst vor Hamstern und die eigene Tinder-Lovestory – Evelyn und Alex, gewohnt offenherzig und herrlich amüsant. Viel Spaß mit der Jubiläumsfolge! Du möchtest mehr über unsere Werbepartner erfahren? Hier findest du alle Infos & Rabatte: https://linktr.ee/AllemeineEltern Du möchtest Werbung in diesem Podcast schalten? Dann erfahre hier mehr über die Werbemöglichkeiten bei Seven.One Audio: https://www.seven.one/portfolio/sevenone-audio
Hey Pickles!Welcome! Here's what's coming up in today's show!In this week's Y Files, Did octopuses come from outer space? We'll explore that possibility!Here's the article: https://cordis.europa.eu/article/id/123479-trending-science-do-octopuses-come-from-outer-spaceIn our Noteworthy segment, We have more on the HHS's dietary guidelines. We'll share the advice that insiders in the meat & dairy industries are receiving from RFK Jr.Here's the article: https://www.farmprogress.com/livestock/rfk-urges-beef-producers-to-expand-herds-as-nutrition-guideline-changesAnd, in Our Main Topic, We'll share some vegan reddit posts, and try to decide…. WHO IS THE ASSHAT!We also have a recipe this week! We'll tell you how you can get a copy of the recipe sent to your inbox.Thanks so much for listening.Stay safe, stay sane, and take care of each other.Much love, Sam & ChristineSend us a text! We can't respond, but we'd love to hear from you!Support the showJoin Our Patreon https://www.patreon.com/CompassionandcucumbersSign Up For Our Newsletterhttps://www.compassionandcucumbers.comOur YouTube https://www.youtube.com/@compassioncucumbersveganpod/videos72 Reasons To Be Vegan *paid link https://amzn.to/3W8ZwsUVisit Our Website https://www.compassionandcucumbers.comSam's Etsy https://www.etsy.com/shop/CucumberCraftworks
When Eric Lefkofsky's wife was diagnosed with breast cancer, it exposed how little technology and data were shaping cancer care, pushing the serial entrepreneur to build a different model.Lefkofsky is the founder and CEO of Tempus, now a $10B publicy traded health tech company, and previously founded Groupon. At Tempus, he's building a tech-first company applying multimodal data and AI to make diagnostics smarter and treatment decisions more tailored, starting in oncology and expanding across disease areas.We cover:What Tempus does in plain EnglishWhy Tempus built its own lab, and how it became one of the largest sequencers of cancer patients in the U.S.The hard part: extracting usable clinical data from EHRs and scaling to thousands of hospital connections and hundreds of petabytes of dataHow AI changes the patient-physician relationship, and why patients will increasingly arrive highly informedWhat Eric would change at CMS and HHS to responsibly pay for AI—About our guest: Eric Lefkofsky is the founder and CEO at Tempus, a leader in artificial intelligence and precision medicine. He is the co-founder and General Partner of Lightbank, a private venture capital firm specializing in investments in technology companies. He is also the co-founder of Pathos AI, a clinical stage biotechnology company focused on re-engineering drug development; Groupon (NASDAQ: GRPN), a global e-commerce marketplace; Mediaocean, a leading provider of integrated media procurement technology; Echo Global Logistics (NASDAQ: ECHO), a technology-enabled transportation and logistics outsourcing firm; and InnerWorkings (NASDAQ: INWK), a global provider of managed print and promotional solutions.He co-chairs the Lefkofsky Family Foundation with his wife Liz to advance high-impact initiatives that enhance lives in the communities served. Lefkofsky also serves on the board of directors of The Art Institute of Chicago and Northwestern Medicine. He holds a bachelor's degree from the University of Michigan and a J.D. from the University of Michigan Law School.—
Welcome to The Daily Wrap Up, an in-depth investigatory show dedicated to bringing you the most relevant independent news, as we see it, from the last 24 hours (2/23/26). As always, take the information discussed in the video below and research it for yourself, and come to your own conclusions. Anyone telling you what the truth is, or claiming they have the answer, is likely leading you astray, for one reason or another. Stay Vigilant. !function(r,u,m,b,l,e){r._Rumble=b,r[b]||(r[b]=function(){(r[b]._=r[b]._||[]).push(arguments);if(r[b]._.length==1){l=u.createElement(m),e=u.getElementsByTagName(m)[0],l.async=1,l.src="https://rumble.com/embedJS/u2q643"+(arguments[1].video?'.'+arguments[1].video:'')+"/?url="+encodeURIComponent(location.href)+"&args="+encodeURIComponent(JSON.stringify([].slice.apply(arguments))),e.parentNode.insertBefore(l,e)}})}(window, document, "script", "Rumble"); Rumble("play", {"video":"v73zypm","div":"rumble_v73zypm"}); Video Source Links (In Chronological Order): Nations Of Sanity Interview - The Non-Aggression Principle Peace Agreement Nations Of Sanity Interview - The Non-Aggression Principle Peace Agreement New Tab New Bill Supported By White House Bypasses RFK Jr's HHS to Fund GAVI Vaccine Alliance Anger as Trump FDA retreats from plan to ban artificial colors in food | Trump administration | The Guardian Trump Ignores MAHA By Ruling Glyphosate "National Security" Imperative Despite Obvious Health Risks (21) Derrick Broze on X: "Here's a few reasons this statement from RFK is garbage: In his first term, Trump continued the trend of nominating industry insiders, namely from chemical companies like DOW and Monsanto (https://t.co/95pFnB8PSL) 2nd, Trump ended investigations into pesticide manufacturers and" / X (21) Truthstream Media on X: "@SecKennedy This you a month ago? https://t.co/Ipuwu05qdX" / X (21) Jasmine Keith on X: "The economy would suffer if we stopped poisoning you. Sorry!" / X (21) healthbot on X: "Environmentalist claims you can drink a whole quart of glyphosate and “it won't hurt you.” The interviewer calls his bluff and offers him a glass of glyphosate. The interview ends 22 seconds later. https://t.co/fBlSViZJuI" / X (21) healthbot on X: "Environmentalist claims you can drink a whole quart of glyphosate and “it won't hurt you.” The interviewer calls his bluff and offers him a glass of glyphosate. The interview ends 22 seconds later. https://t.co/fBlSViZJuI" / X (21) The Last American Vagabond on X: "#Winning https://t.co/IcQ7RMqX28" / X New Tab U.S. considers building pricey alternative to World Health Organization - The Washington Post Gaza's "Board Of Peace" Seeks To Reimagine The International Order New Bill Supported By White House Bypasses RFK Jr's HHS to Fund GAVI Vaccine Alliance Trump At Davos: Globalism Is Dead. Long Live Globalism. The Fake Globalist Resistance Ushering In The Globalist Plan Trump & The Zionist/Globalist Technocrats Are Building Your New Society Whether You Like It Or Not The Network State Coup And The Engineered Transition To "Tech Zionism" (21) Dan Smotz (The System is Down) on X: "The “woke agenda” was just rebranded like MK Ultra and every other government propaganda program that gets caught." / X (21) Red Line News on X: "@DefiantLs We definitely tried" / X Trump Has Been Secretly Texting His Favorite Dem Zohran Mamdani New Tab (21) Kevork Almassian on X: "Neil Oliver says the quiet part out loud in this segment and the direction of what he's describing is hard to ignore. He argues the project isn't just “left vs right” or one crisis after another, but a long campaign to break what makes people human — identity, heritage, faith, https://t.co/BA2Cs8uIF7" / X (21) Axiomatic Enemy of the State on X: "https://t.co/UoqY3lgeNw" / X (21) Liam McCollum on X: "BBC News is reporting now that Lord Peter Mandelson was just arrested on suspicion of misconduct in public office after the ex-US ambassador had been under investigation over allegations he shared market-sensitive government information with Jeffrey Epstein while a minister. He" / X Police in Britain arrest former ambassador to US Peter Mandelson in probe into Epstein ties | AP News Former Prince Andrew arrested months after losing royal status (21) The Atlantic on X: "The Epstein files reveal that plenty of powerful people tolerated or participated in disgusting, shameful, and even criminal behavior—but they also bolster the case that there never was any grand conspiracy, @GiladEdelman argues. https://t.co/1bOtPSxuvQ" / X Allegations in Epstein files may amount to 'crimes against humanity,' UN experts say | Reuters (21) DD Geopolitics on X: "The Pentagon offered JEFFERY EPSTEIN a $116M "mission-critical" location to operate next to them in “the only property in Arlington other than the Pentagon with the ability to meet the needs of the DOD” and did it through Prince Andrew's aide. In 2015 he was offered the FBI" / X (21) RT on X: "Lolita Express lands at MILITARY bases Ghislaine: ‘Sh*t' https://t.co/hZACO29dZO" / X EFTA01837627.pdf FBI's “Stand Down” Directive to NYPD on Jeffrey Epstein Investigations, and More Jeffrey Epstein hid secret files in storage units across US (21) James Li on X: "James Comer claims that the DOJ had already "investigated" Les Wexner, but in the deposition released yesterday, Wexner clearly states that no one from the FBI or DOJ had ever spoken to him about Epstein or Ghislaine Maxwell. Either he's lying, or they are both lying.
Oral Arguments for the Court of Appeals for the D.C. Circuit
Vertex Pharmaceuticals Incorporated v. HHS
Join Dr. Libby Crockett as she talks with Joanna Murray and Cleo Zagurski from the Reproductive Health Collaborative, Nebraska to learn about Title X in the State of Nebraska and how HR1 affects the delivery of reproductive healthcare in our state.Reproductive Health Collaborative Nebraska Advocacy Ask: Contact your U.S. Senators and Representative and urge them to reach out to HHS and demand the immediate release of the Title X - Year 5 non-compete continuation application and guidance. Nebraska stands to lose over $2 million dollars for the coming year if Title X funding is not released, which will lead to possible clinic closures and Nebraskans not receiving life-saving preventative care. Senator Fischer's Office: 202-224-6551 Senator Ricketts' Office: 202-224-4224Representative Flood's Office: 202-225-4806 Representative Bacon's Office: 402-938-0300 Representative Smith's Office: 308-384-3900 Reproductive Health Collaborative Nebraska Links: https://rhcnebraska.org/https://incontrolnebraska.com/Link to HR1 - One Big Beautiful Bill Acthttps://www.congress.gov/bill/119th-congress/house-bill/1If you have questions or answers, please email us at contact@nebraskaallianceforphysicianadvocacy.org Please check out our website at: https://nebraskaallianceforphysicianadvocacy.org/Nebraska Alliance for Physician Advocacy Follow on social media: @NEAllianceforPhysicianAdvocacy on Instagram https://www.facebook.com/neallianceforphysicianadvocacy on Facebook The views and opinions expressed on this podcast are solely those of the speakers and guests and do not necessarily reflect the official policy or position of their employers or any other organization or entity. This podcast is for informational and entertainment purposes only and does not constitute professional medical, legal, or financial advice. If you have a specific concern, please consult with a qualified professional.
Welcome to The Daily Wrap Up, an in-depth investigatory show dedicated to bringing you the most relevant independent news, as we see it, from the last 24 hours (2/20/26). As always, take the information discussed in the video below and research it for yourself, and come to your own conclusions. Anyone telling you what the truth is, or claiming they have the answer, is likely leading you astray, for one reason or another. Stay Vigilant. !function(r,u,m,b,l,e){r._Rumble=b,r[b]||(r[b]=function(){(r[b]._=r[b]._||[]).push(arguments);if(r[b]._.length==1){l=u.createElement(m),e=u.getElementsByTagName(m)[0],l.async=1,l.src="https://rumble.com/embedJS/u2q643"+(arguments[1].video?'.'+arguments[1].video:'')+"/?url="+encodeURIComponent(location.href)+"&args="+encodeURIComponent(JSON.stringify([].slice.apply(arguments))),e.parentNode.insertBefore(l,e)}})}(window, document, "script", "Rumble"); Rumble("play", {"video":"v73v1co","div":"rumble_v73v1co"}); Video Source Links (In Chronological Order): The Fake Globalist Resistance Ushering In The Globalist Plan Trump & The Zionist/Globalist Technocrats Are Building Your New Society Whether You Like It Or Not Gaza's "Board Of Peace" Seeks To Reimagine The International Order (21) Derrick Broze on X: "$10 billion of US taxpayer dollars to Trump's "Board of Peace"." / X (21) Slow News Day on X: "This is the exact same currency model the US wants for Americans, same with the UK/EU, Russia, China, & every other nation We all live on Planet Gaza" / X (21) Truthstream Media on X: "Interesting Dept of War propaganda released on the same day Trump announces he's taking $10B out of the US Treasury without approval from our impotent Congress to transfer to the Board of Peace slush fund he created and made himself chairman for life. https://t.co/33g9a8KBSM" / X New Tab (21) Rand Paul on X: "In defense of our Republic, the Supreme Court struck down using emergency powers to enact taxes. This ruling will also prevent a future President such as AOC from using emergency powers to enact socialism." / X (21) Okiesmokey on X: "@BenjaminPDixon @RandPaul https://t.co/s1abiAEx8R" / X (21) Liam McCollum on X: "@RepThomasMassie Importantly:" / X (21) JD Vance on X: "Today, the Supreme Court decided that Congress, despite giving the president the ability to "regulate imports", didn't actually mean it. This is lawlessness from the Court, plain and simple. And its only effect will be to make it harder for the president to protect American" / X (21) Justin Amash on X: "According to JD Vance, a Supreme Court decision that upholds the law and halts lawlessness is the real lawlessness. And then he gripes about the president's power being limited. Yes, that's the point of the Constitution. The Framers deliberately constrained the president." / X (21) Mike Young on X: "@SpeakerJohnson Yes, tariffs brought in revenue. They also raised prices on groceries, cars, and farm equipment while inviting retaliation against our exporters. If we truly want to honor American workers, we should choose policies that cut their costs and expand their markets, not ones that" / X (21) Bark on X: "Realizing American citizens paid $175 billion in illegal tariffs and it's being refunded to companies instead of back to us. https://t.co/uKA3HoB6mU" / X (21) Everything is Stupid on X: "@DefiantLs https://t.co/w9AQqPptea" / X (21) The White House on X: "MAKE AMERICA GREAT AGAIN! https://t.co/un5zFbSEJl" / X New Tab (21) Aaron Day on X: "This is the most corrupt admin in US history. I'm not being hyperbolic." / X (21) Max Blumenthal on X: "Trump Inc corruption is so extensive it's difficult to keep tabs Besides cashing in on the tariff policy he personally engineered, financial sleazelord Howard Lutnick is also deregulating crypto while holding a $600 million stake in Tether To paper over the conflict of" / X (21) TenthAmendmentCenter on X: "CORRUPTION, PLUNDER & WASTE Thomas Jefferson said that's just what we'd get with too much centralized power. He warned us. We didn't listen. “our country is too large to have all it's affairs directed by a single government. public servants at such a distance, & from under" / X (21) Aaron Day on X: "The Trump administration is peak corruption." / X (21) Ed Krassenstein on X: "BREAKING: Eric Trump and Don Jr. just said the quiet part out loud! CNBC: "You know what the critics would say… Everyone is here to curry favor." The Trumps: “There is a great honor here. They didn't give us much of a choice. They created this monster!... We just realized https://t.co/nt27qZHLc6" / X (21) Cuckturd on X: "Trump & his kids are opening their own Polymarket. They can now personally profit off every House vote, press conference, executive order, Tariff decision. You name it. Haven't heard the Trump's talk about Burisma for a while.
TW: there is a story about sexual assault of minors around the time stamp 14:10-21. Our Feminist Buzzkill Lizz is solo this week, serving you a pod full of horror — but with that super sweet pro-abortion cherry on top! She brings you up to speed on the latest WTAF reports of the government rounding up pregnant migrant teens and shipping them to a Texas prison known for not providing adequate healthcare. Yes, you read that right. Add in increased cases of pregnancy criminalization and the Right's continued crusade against abortion pills out of Kentucky and Louisiana, and we're ready to just nope right the fuck off this planet. GUEST ROLL CALL: Becca Rea-Tucker, The Sweet Feminist, is here to chat about her new book, The Abortion Companion handbook and allllll things abortion! Pro-abortion cakes AND supporting abortion seekers? WHAT MORE COULD YOU ASK FOR?! Times are heavy, but knowledge is power, y'all. We gotchu. OPERATION SAVE ABORTION: You can still join the 10,000+ womb warriors fighting the patriarchy by clicking HERE to for past Operation Save Abortion trainings, your toolkit, marching orders, and more. HOSTS: Lizz Winstead IG: @LizzWinstead Bluesky: @LizzWinstead.bsky.social Moji Alawode-El IG: @Mojilocks Bluesky: @Mojilocks.bsky.social SPECIAL GUESTS: Becca Rea-Tucker IG: @TheSweetFeminist Bluesky: @TheSweetFeminist.bsky.social GUEST LINKS: BUY: Becca's handbook, “The Abortion Companion” The Abortion Companion Book Swap The Sweet Feminist Website Becca's Linktree BUY: Becca's Baking Book SIGN UP: Becca's Substack AVOW Texas Expose Fake Clinics NEWS DUMP: KY Couple Arrested, Charged With Reckless Homicide After Reporting Miscarriage Abortion Pills Would Be Classified as Controlled Substances Under New Bill Republican US Senators File Amicus Brief to Eliminate the Mailing of Chemical Abortion Drugs, Including Mifepristone Judge Rejects Anti-Abortion Center's Lawsuit Against Top Massachusetts Officials Trump Administration Is Sending Pregnant Migrant Girls to South Texas Shelter Flagged as Medically Inadequate AAF Breakdown on Pregnant Incarceration AAF RESOURCE: Hypocrites Unmasked EPISODE LINKS: BUY: Michael Shannon / Jason Narducy & Friends Lifes Poster TICKETS: Michael Shannon & Jason Narducy Tour ADOPT-A-CLINIC: Emma Goldman Clinic in Iowa City, IA Operation Save Abortion Expose Fake Clinics BUY AAF MERCH! EMAIL your abobo questions to The Feminist Buzzkills AAF's Abortion-Themed Rage Playlist FOLLOW US: Listen to us ~ FBK Podcast Instagram ~ @AbortionFront Bluesky ~ @AbortionFront TikTok ~ @AbortionFront Facebook ~ @AbortionFront YouTube ~ @AbortionAccessFront TALK TO THE CHARLEY BOT FOR ABOBO OPTIONS & RESOURCES HERE! PATREON HERE! Support our work, get exclusive merch and more! DONATE TO AAF HERE! ACTIVIST CALENDAR HERE! VOLUNTEER WITH US HERE! ADOPT-A-CLINIC HERE! GET ABOBO PILLS FROM PLAN C PILLS HERE! When BS is poppin', we pop off! Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Health Affairs' Jeff Byers welcomes Christina Farr, CEO and editor-in-chief of Second Opinion Media, back to the pod to discuss her book, The Storyteller's Advantage: How Powerful Narratives Make Businesses Thrive. The conversation explores the value of storytelling in the health care and health policy space, how to invest in posting, the catch 22 of "spicy takes," recommendations for the reluctant poster, and Christina shares a quick look into what's interesting in the digital health investment space.
In this in-depth episode of the Whole Body Detox Show, David DeHaas sits down with Charles Froman to unpack one of the most controversial infrastructure debates in America today: 5G expansion vs. fiber optic broadband, copper landline removal, and federal telecom policy.The discussion explores allegations of diverted landline surcharges, BEAD taxpayer funding, and whether wireless deployment is being prioritized over long-term fiber solutions. They examine concerns surrounding FCC preemption laws, state zoning authority, and proposed federal bills that could limit local control over cell tower placement.Key topics include:• Fiber optics vs. wireless broadband performance and longevity • Copper landlines as critical emergency infrastructure during disasters • 4G/5G tower proximity to homes and schools • Energy consumption and the environmental footprint of wireless networks • Precision agriculture, RFID livestock monitoring, and rural transmitter expansion • Reported impacts on dairy farms, pollinators, forests, and wildlife • Data monetization, telecom profits, and infrastructure replacement cycles • RFK Jr.'s ordered HHS study into wireless health effects • Property rights, informed consent, and community safetyThe core issue: Can we have modern broadband convenience without sacrificing public health, environmental stewardship, agricultural stability, and local governance?This episode highlights the ongoing debate over safe technology deployment, rural broadband policy, and the future of wired vs. wireless infrastructure in America.DM “SAFE TECH” to learn how to stay informed and protect your home, family, and community.
In episode 2009, Jack and guest co-host Pallavi Gunalan are joined by comedian, actor, and host of Podcast But Outside, Andrew Michaan, to discuss… RFK Jr. And Kid Rock Team Up For Workout Video/Cringe Comedy Masterclass, We Need to Talk About Piven Experience, The Epstein Files Just Derailed Jimmy Fallon’s Pasta Sauce Plans and more! RFK Jr. And Kid Rock Team Up For Workout Video/Cringe Comedy Masterclass ‘What the [bleep] did I just watch?’ RFK Jr. posts workout video with Kid Rock urging Americans to ‘get active’ Conservatives trying to put Tim Heidecker out of a job. Another Controversial Stance From RFK Jr: Working Out in Jeans Inside Kid Rock's Massive White House Replica with Golden Urinal Kid Rock RFK Rock Out Work Out Has Dropped And We’ll Never Be The Same The Epstein Files have smashed Jimmy Fallon’s spaghetti sauce dreams Jimmy Fallon Kills Planned Pasta Sauce Line With Pal Tommy Mottola as Epstein Friendship Is Revealed This is the trademark for the sauce venture that Jimmy Fallon and Tommy Mottola were launching Soon Yi Previn Shades Fallon in Epstein Files Email Jimmy Debuts New P'Jimmies Summer Line | The Tonight Show Starring Jimmy Fallon Awkward Moment Between Paris Hilton And Jimmy Fallon Highlights The Absurdity Of NFTs Celebrity Promoters Sued Over Bored Ape NFT Endorsements Xochitl Welcomes Jimmy Fallon as an Investor and Brand Partner Helen Mirren and Pierce Brosnan Try Jimmy's Celebrity Tomato Salsa, Talk The Thursday Murder Club Eli Manning, Derek Jeter, Jimmy Fallon join TGL New York Golf Club investor group A short-seller has challenged Jimmy Fallon to a $1 million bet over an air-taxi company he's promoted LISTEN: Robbed You (with Mariah the Scientist) by Summer WalkerSee omnystudio.com/listener for privacy information.
Melissa Lavasani & Jay Kopelman join our podcast to discuss how psychedelic policy is actually moving in Washington, DC. Lavasani leads Psychedelic Medicine Coalition, a DC-based advocacy organization focused on educating federal officials and advancing legislation around psychedelic medicine. Kopelman is CEO of Mission Within Foundation, which provides scholarships for veterans and first responders seeking psychedelic-assisted therapy retreats, often outside the United States. The conversation centers on veterans, the VA, and why that system may be the first realistic federal pathway for psychedelic care. Early Themes Lavasani describes PMC's work on Capitol Hill, including hosting events that bring lawmakers, staffers, and advocates into the same room. Her focus is steady engagement. In DC, progress often happens through repeated conversations, not headlines. Kopelman shares his background as a Marine and how his own psychedelic-assisted therapy experience led him to Mission Within. The foundation has funded more than 250 scholarships for veterans and first responders seeking treatment for PTSD, mild traumatic brain injury, depression, and addiction. They connect this work to pending veteran-focused legislation and explain why the VA matters. As a closed health system, the VA can pilot programs, gather data, and refine protocols without the pressures of private healthcare markets. Core Insights A recent Capitol Hill gathering, For Veteran Society, brought together members of Congress and leaders from the psychedelic caucus. Lavasani describes candid feedback from lawmakers. The message was clear: coordinate messaging, avoid fragmentation, and move while bipartisan interest remains. Veteran healthcare is not framed as the final goal. It is a starting point. If psychedelic therapies can demonstrate safety and effectiveness within the VA, broader adoption becomes more plausible. Kopelman raises operational realities that must be addressed: Standardized safety protocols across providers Integration support, not medication alone Clear training pathways for clinicians Real-world data beyond tightly screened clinical trials They also address recent negative headlines involving ibogaine treatment abroad. Kopelman emphasizes the need for shared learning across providers, especially when adverse events occur. Lavasani argues that inconsistency within the ecosystem can slow federal confidence. Later Discussion and Takeaways The discussion widens to federal momentum around addiction and mental health. Lavasani notes that new funding initiatives signal growing openness to innovative treatment models, even if psychedelics are not named explicitly in every announcement. Both guests stress that policy moves slowly by design. Meetings, follow-ups, and relationship building often matter more than public statements. For clinicians, researchers, operators, and advocates, the takeaways are direct: Veterans are likely the first federal pathway Public education remains essential Safety standards must be shared and transparent Integration and workforce development need attention now If psychedelic medicine enters federal systems, infrastructure will determine success. Frequently Asked Questions What do Melissa Lavasani & Jay Kopelman say about VA psychedelic policy? They argue that veteran-focused legislation offers a realistic first federal pathway for psychedelic-assisted care. Is ibogaine currently available through the VA? No. They discuss ibogaine in the context of private retreats and future possibilities, not an existing VA program. Why do Melissa Lavasani & Jay Kopelman emphasize coordination? Lawmakers respond more positively when advocates present aligned messaging and clear priorities. What safety issues are discussed by Melissa Lavasani & Jay Kopelman? They highlight the need for standardized screening, monitoring, integration support, and transparent review of adverse events. Closing Melissa Lavasani & Jay Kopelman provide a grounded look at how psychedelic policy develops inside federal systems. Their message is practical: veterans may be the first lane, but long-term success depends on coordination, safety standards, and sustained engagement. Closing This episode captures a real-time view of how federal policy could shape the next phase of the psychedelic resurgence, especially through veteran-facing legislation and VA infrastructure. Melissa Lavasani & Jay Kopelman argue that coordination, public education, and shared safety standards will shape whether access expands with credibility and care. Transcript Joe Moore: [00:00:00] Hello everybody. Welcome back to Psychedelics Today. Today we have two guests, um, got Melissa Sani from Psychedelic Medicine Coalition. We got Jake Pelman from Mission Within Foundation. We're gonna talk about I bga I became policy on a recent, uh, set of meetings in Washington, DC and, uh, all sorts of other things I'm sure. Joe Moore: But thank you both for joining me. Melissa Lavasani: Thanks for having us. Jay Kopelman: Yeah, it's a pleasure. Thanks. Joe Moore: Yeah. Um, Melissa, I wanna have you, uh, jump in. First. Can you tell us a little bit about, uh, your work and what you do at PMC? Melissa Lavasani: Yeah, so Psychedelic Medicine Coalition is, um, the only DC based Washington DC based advocacy organization dedicated to the advancing the issue of psychedelics, um, and making sure the federal government has the education they need, um, and understands the issue inside out so that they can generate good policy around, around psychedelic medicines. Melissa Lavasani: [00:01:00] Uh, we. Host Hill events. We host other convenings. Our big event every year is the Federal Summit on psychedelic medicine. Um, that's going to be May 14th this year. Um, where we talk about kinda the pressing issues that need to be talked about, uh, with government officials in the room, um, so that we can incrementally move this forward. Melissa Lavasani: Um, our presence here in Washington DC is, is really critical for this issue's success because, um, when we're talking about psychedelic medicines, um, from the federal government pers perspective, you know, they are, they are the ones that are going to initiate the policies that create a healthcare system that can properly facilitate these medicines and make sure, um, patient safety is a priority. Melissa Lavasani: And there's guardrails on this. And, um, you know, there, it's, it's really important that we have. A home base for this issue in Washington DC just [00:02:00] because, uh, this is very complicated as a lot of your viewers probably understand, and, you know, this can get lost in the mix of all the other issues that, um, lawmakers in DC are focused on right now. Melissa Lavasani: And we need to keep that consistent presence here so that this continues to be a priority for members of Congress. Joe Moore: Mm. I love this. And Jay, can you tell us a bit about yourself and mission within Foundation? Jay Kopelman: Yeah, sure. Joe, thanks. Uh, I, I am the CEO of Mission within Foundation. Prior to this, most of my adult life was spent in the military as a Marine. Jay Kopelman: And I came to this. Role after having, uh, a psychedelic assisted therapy experience myself at the mission within down in Mexico, which is where pretty much we all go. Um, we are here to help [00:03:00] provide, uh, access for veterans and first responders to be able to attend psychedelic assisted therapy retreats to treat issues like mild TBI, post-traumatic stress disorder, uh, depression, sometimes addiction at, at a very low level. Jay Kopelman: Um, and, and so we've, we've been doing this for a little more than a year now and have provided 250 plus scholarships to veterans and first responders to be able to access. These retreats and these, these lifesaving medicines. Um, we're also partnered, uh, you may or may not know with Melissa at Psychedelic Medicine Coalition to help advance education and policy, specifically the innovative, uh, therapy Centers of Excellence Act [00:04:00] that Melissa has worked for a number of years on now to bring to both Houses of Congress. Joe Moore: Thank you for that. Um, so let's chat a little bit about what this event was that just, uh, went down, uh, what, what was it two weeks ago at this point? Melissa Lavasani: Yeah. Yeah. It's called For Veteran Society and it's all, um, there's a lot of dialogue on Capitol Hill about veterans healthcare and psychedelics, but where I've been frustrated is that, you know, it was just a lot of. Melissa Lavasani: Talk about what the problems are and not a lot of talk about like how we actually propel things forward. Um, so it, at that event, I thought it was really important and we had three members of Congress there, um, Morgan Latrell, who has been a champion from day one and his time in Congress, um, having gone through the experience himself, um, [00:05:00] at Mission within, um, and then the two chairs of the psychedelic caucus, uh, Lou Correa and Jack Bergman. Melissa Lavasani: And we really got down to the nitty gritty of like w like why this has taken so long and you know, what is actually happening right now? What are the possibilities and what the roadblocks are. And it was, I thought it was a great conversation. Um, we had an interesting kind of dynamic with Latres is like a very passionate about this issue in particular. Melissa Lavasani: Um, I think it was, I think it was really. A great event. And, you know, two days later, Jack Bergman introduced his new bill for the va. Um, so it was kind of like the precursor to that bill getting introduced. And we're just excited for more and more conversations about how the government can gently guide this issue to success. Joe Moore: Hmm. Yeah. [00:06:00] That's fantastic. Um, yeah, I was a little bummed I couldn't make it, but next time, I hope. But I've heard a lot of good things and, um, it's, it sounded like there was some really important messages in, in terms of like feedback from legislators. Yeah. Yeah. Could you speak to that? Melissa Lavasani: Yeah, I mean, I think when, uh, representative Latrell was speaking, he really impressed on us a couple things. Melissa Lavasani: Um, first is that, you know, they really kind of need the advocates to. Coordinate, collaborate and come up with like a, a strategic plan, you know, without public education. Um, talking to members of Congress about this issue is, is really difficult. You know, like PMC is just one organization. We're very little mission within, very little, um, you know, we're all like, kind of new in navigating, um, this not so new issue, but new to Washington DC [00:07:00] issue. Melissa Lavasani: Um, without that public education as a baseline, uh, it's, it's, you have to spend a lot of time educating members of Congress. You know, that's like one of our things is, you know, we have to, we don't wanna tell Congress what direction to go to. We wanna provide them the information so they understand it very intimately and know how to navigate through things. Melissa Lavasani: Um, and secondly. Um, he got pretty frank with us and said, you know, we've got one cha one chance at this issue. And it's like, that's, that's kind of been like my talking point since I started. PMC is like, you have a very limited window, um, when these kind of issues pop up and they're new and they're fresh and you have a lot of the veteran community coming out and talking about it. Melissa Lavasani: And there's a lot of energy there. But now is the time to really move forward, um, with some real legislation that can be impactful. Um, but, you know, we've gotta [00:08:00] be careful. We, we forget, I think sometimes those of us who are in the ecosystem forget that our level of knowledge about these medicines and a lot of us have firsthand experience, um, with these drugs and, and our own healing journeys is, um, we forget that there is a public out there that doesn't have the level of knowledge that we all have. Melissa Lavasani: And, um. We gotta make sure that we're sticking to the right elements of, of, of what needs to happen. We need to be sure that our talking points are on track and we're not getting sideways about anything and going down roads that we don't need to talk about. It's why, um, you know, PMC is very focused on, um, moving forward veteran legislation right now. Melissa Lavasani: Not because we're a veteran organization, but because we're, we see this long-term policy track here. Um, we know where we want to get [00:09:00] to, um. Um, and watching other healthcare issues kind of come up and then go through the VA healthcare system, I think it's a really unique opportunity, um, to utilize the VA as this closed system, the biggest healthcare system in the country to evaluate, uh, how psychedelics operate within systems like that. Melissa Lavasani: And, you know, before they get into, um, other healthcare systems. What do we need to fix? What do we need to pay attention to? What's something that we're paying too much attention to that doesn't necessarily need that much attention? So it's, um, it's a real opportunity to look at psychedelic medicines within a healthcare system and obviously continue to gather the data. Melissa Lavasani: Um, Bergman's Bill emerging, uh, expanding veteran access to emerging treatments. Um, not only mandates the research, it gives the VA authority for this, uh, for running trials and, and creating programs around psychedelic medicines. But also, [00:10:00] one of the great things about it, I think, is it provides an on-ramp for veterans that don't necessarily qualify for clinical trials. Melissa Lavasani: You know, I think that's one of the biggest criticisms of clinical trials is like you're cre you're creating a vacuum for people and people don't live in a vacuum. So we don't necessarily know what psychedelics are gonna look like in real life. Um, but with this expanding veteran access bill that Bergman introduced, it provides the VA an opportunity to provide this access under. Melissa Lavasani: Um, in a, in a safe container with medical supervision while collecting data, um, while ensuring that the veteran that is going through this process has the support systems that it needs. So, um, you know, I think that there's a really unique opportunity here, and like Latrell said, like, we've got one shot at this. Melissa Lavasani: We have people's attention in Congress. Um, now's the time to start acting, and let's be really considerate and thoughtful about what we're doing with it. Joe Moore: Thanks for that, Melissa and Jay, how, [00:11:00] anything to add there on kind of your takeaways from the this, uh, last visit in dc? Jay Kopelman: Yeah, I, I think that Melissa highlighted it really well and there, there were a couple other things that I, I think, you know, you could kind of tie it all together with some other issues that we face in this country, uh, and that. Jay Kopelman: Uh, representative Correa brought up as well, but one of the things I wanted to go back and say is that veterans have kind of led this movement already, right? So, so it's a, it's a good jumping off point, right? That it's something people from both sides of the aisle, from any community in America can get behind. Jay Kopelman: You know, if you think about it, uh, in World War ii, you know, we had a million people serving our population was like, not even 200 million, but now [00:12:00] we have a population of 330 million, and at any given time there might be a million people in uniform, including the Reserve and the National Guard. So it's, it, it's an easy thing to get behind this small part of the population that is willing to sign that contract. Jay Kopelman: Where you are saying, yeah, I'm going to defend my country, possibly at the risk of my l my own life. So that's the first thing. The other thing is that the VA being a closed health system, and they don't have shareholders to answer to, they can take some risks, they can be innovative and be forward thinking in the ways that some other healthcare systems can't. Jay Kopelman: And so they have a perfect opportunity to show that they truly care for their veterans, which don't, I'm not saying they don't, but this would be an [00:13:00] opportunity to show that carrot at a whole different level. Uh, it would allow them to innovate and be a leader in something as, uh, as our friend Jim Hancock will say, you know. Jay Kopelman: When he went to the Naval Academy, they had the world's best shipbuilding program. Why doesn't the VA have the world's best care program for things like TBI and PTSD, which affects, you know, 40 something percent of all veterans, right? So, so there's, there's an opportunity here for the VA to lead from the front. Jay Kopelman: Um, the, these medicines provide, you know, reasonably lasting care where it's kind of a one and done. Whereas with the current systems, the, you know, and, and [00:14:00] again, not to denigrate the VA in any way, they're doing the best job they can with the tools in their toolbox, right? But maybe it's time for a trip to Home Depot. Jay Kopelman: Let's get some new tools. And have some new ways of fixing what's broken, which is really the way of doing things. It's not, veterans aren't broken, we are who we are. Um, but it's a, it's a way to fix what isn't working. So I, I think that, you know, given there's tremendous veteran homelessness still, you know, addiction issues, all these things that do translate to the population at large are things that can be worked on in this one system, the va that can then be shown to have efficacy, have good data, have [00:15:00] good outcomes, and, and take it to the population at large. Joe Moore: Mm-hmm. Brilliant. Thanks for that. And so there was another thing I wanted to pivot to, which is some of the recent press. So we've, um, seen a little bit of press around some, um, in one instance, some bad behavior in Mexico that a FI put out Americans thrive again, put out. And then another case there was a, a recent fatality. Joe Moore: And I think, um, both are tragic. Like we shouldn't be having to deal with this at this point. Um, but there's a lot of things that got us here. Um, it's not necessarily the operator's fault entirely, um, or even at all, honestly, like some medical interventions just carry a lot of risk. Like think, think about like, uh, how risky bypass surgery was in the nineties, right? Joe Moore: Like people were dying a lot from medical interventions and um, you know, this is a major intervention, uh, ibogaine [00:16:00] and also a lot of promise. To help people quite a bit. Um, but as of right now, there's, there's risk. And part of that risk, in my opinion, comes from the inability of organizations to necessarily collaborate. Joe Moore: Like there's no kind of convening body, sitting in the middle, allowing, um, for, and facilitating really good data sharing and learnings. Um, and I don't, I don't necessarily see an organization stepping up and being the, um, the convener for that kind of work. I've heard rumors that something's gonna happen there, and I'm, I'm hopeful I'll always wanna share my opinion on that. Joe Moore: But yeah. I don't know. Jay, from your perspective, is there anything you want to kind of speak to about, uh, these two recent incidents that Americans for Iboga kind of publicized recently? Jay Kopelman: Yeah, so I, I'll echo your sentiment, of course, that these are tragic incidents. Um, and I, [00:17:00] I think that at least in the case of the death at Ambio, AMBIO has done a very good job of talking about it, right? Jay Kopelman: They've been very honest with the information that they have. And like you said, there are risks inherent to these medicines, and it's like anything else in medicine, there are going to be risks. You know, when I went through, uh, when I, when I went through chemo, you know, there were, there are risks. You know, you don't feel well, you get sick. Jay Kopelman: Um, and, and it. There are processes in place to counter that when it happens. And there are processes and, and procedures and safety protocols in place when caring for somebody going through an ibogaine [00:18:00] journey. Uh, when I did it, we had EKG echocardiogram. You're on a heart monitor the entire time they push magnesium via iv. Jay Kopelman: You have to provide a urinalysis sample to make sure that there is nothing in your system that is going to potentially harm you. During the ibogaine, they have, uh, a cardiologist who is monitoring the heart monitors throughout the ibogaine experience. So the, the safety protocols are there. I think it's, I think it's just a matter of. Jay Kopelman: Standardizing them across all, all providers, right? Like, that would be a good thing if people would talk to one another. Um, as, as in any system, right? You've gotta have [00:19:00] some collaboration. You've gotta have standardization, you know, so, you know, they're not called standard operating procedures for nothing. Jay Kopelman: That means that in a, you know, in a given environment, everybody does things the same way. It's true in Navy and Marine Corps, air Force, army Aviation, they have standard operating procedures for every single aircraft. So if you fly, let's say the F 35 now, right? Because it's flown by the Navy, the Marine Corps, and the Air Force. Jay Kopelman: The, the emergency procedures in that airplane are standardized across all three services, so you should have the same, or, you know, with within a couple of different words, the same procedures and processes [00:20:00] across all the providers, right? Like maybe in one document you're gonna change, happy to glad and small dog to puppy, but it's still pretty much the, the same thing. Jay Kopelman: And as a service that provides scholarships to people to go access these medicines and go to these retreats, you know, my criteria is that the, this provider has to be safe. Number one, safety's paramount. It's always gotta be very safe. It should, it has to be effective. And you know, once you have those two things in place, then I have a comfort level saying, okay, yeah, we'll work with this provider. Jay Kopelman: But until those standardized processes are in place, you'll probably see these one-off things. I mean, some providers have been doing this longer than others and have [00:21:00] really figured out, you know, they've, they've cracked the code and, you know, sharing that across the spectrum would be good. Um, but just when these things happen, having a clearing house, right, where everybody can come together and talk about it, you know, like once the facts are known because. Jay Kopelman: To my knowledge, we still don't know all the facts. Like as, you know, as horrible as this is, you still have to talk about like an, has an autopsy been performed? What was found in the patient's system? You know, there, there are things there that we don't know. So we need to, we need to know that before we can start saying, okay, well this is how we can fix that, because we just don't know. Jay Kopelman: And, you know, to their credit, you know, Amio has always been safe to, to the, to the best of my knowledge. You know, I, [00:22:00] I haven't been to Ambio myself, but people that I have worked with have been there. They have observed, they have seen the process. They believe it's safe, and I trust their opinion because they've seen it elsewhere as well. Jay Kopelman: So yeah, having, having that one place where we can all come together when this happens, it, it's almost like it should be mandatory. In the military when there's a training accident, we, you know, we would have to have what's called a safety standout. And you don't do that again for a little while until you figure out, okay, how are we going to mitigate that happening again? Jay Kopelman: Believe me, you can go overboard and we don't want to do that. Like, we don't wanna just stop all care, but maybe stop detox for a week and then come back to it. [00:23:00] Joe Moore: Yeah. A dream would be, let's get like the, I don't know, 10, 20 most popular, uh, or well-known operators together somewhere and just do like a three day debrief. Joe Moore: Hey, everybody, like, here's what we see. Let's work on this together. You know how normal medicine works. And this is, it's hard because this is not necessarily, um, something people feel safe about in America talking about 'cause it's illicit here. Um, I don't understand necessarily how the operations, uh, relate to each other in Mexico, but I think that's something to like the public should dig into. Joe Moore: Like, what, what is this? And I, I'll start digging into that. Um, I, I asked a question recently of somebody like, is there some sort of like back channel signal everybody's using and there's no clear Yes. You know? Um, I think it would be good. That's just a [00:24:00] start, you know, that's like, okay, we can actually kind of say hi and watch out for this to each other. Jay Kopelman: It's not like we don't all know one another, right? Joe Moore: Yes. Jay Kopelman: Like at least three operators we're represented. At the Aspen Ibogaine meeting. So like that could be, and I think there was a panel kind of loosely related to this during Aspen Ibogaine meeting, but Joe Moore: mm-hmm. Jay Kopelman: It, you know, have a breakout where the operators can go sit down and kind of compare notes. Joe Moore: Right. Yeah. Melissa, do you have any, uh, comments on this thread here? And I, I put you on mute if you didn't see that. Um, Melissa Lavasani: all right, I'm off mute. Um, yeah, I think that Jay's hits the nail on the head with the collaboration thing. Um, I think that it's just a [00:25:00] problem across the entire ecosystem, and I think that's just a product of us being relatively new and upcoming field. Melissa Lavasani: Um, uh, it's a product of, you know. Our fundraising community is really small, so organizations feel like they are competing for the same dollars, even though their, their goals are all the same, they have different functions. Um, I think with time, I mean, let's be honest, like if we don't start collaborating and, and the federal government's moving forward, the federal government's gonna coordinate for us. Melissa Lavasani: And not, that might not necessarily be a bad thing, but, you know, we understand this issue to a whole other level that the federal government doesn't, and they're not required to understand it deeply. They just need to know how to really move forward with it the proper way. Um, but I think that it. It's really essential [00:26:00] that we all have this come together moment here so we can avoid things. Melissa Lavasani: Uh, I mean, no one's gonna die from bad advocacy. So like I've, I have a bit of an easier job. Um, but it can a, a absolutely stall efforts, um, to move things forward in Washington DC when, um, one group is saying one thing, another group is saying another thing, like, we're not quite at a point yet where we can have multiple lines of conversation and multiple things moving forward. Melissa Lavasani: Um, you know, for PMC, it's like, just let's get the first thing across the finish line. And we think that is, um, veteran healthcare. And, um, I know there's plenty of other groups out there that, that want the same thing. So, you know, I always, the reason why I put on the Federal Summit last year was I kind of hit my breaking point with a lack of collaboration and I wanted to just bring everyone in the same room and say like, all right, here are the things that we need to talk about. Melissa Lavasani: And I think the goal for this year is, um. To bring people in the same room and say, we talked about [00:27:00] we scratched the surface last year and this is where we need to really put our efforts into. And this is where the opportunities are. Um, I think that is going to, that's going to show the federal government if we can organize ourselves, that they need to take this issue really seriously. Melissa Lavasani: Um, I don't think we've done a great job at that thus far, but I think there's still plenty of time for us to get it together. Um, and I'm hoping with these two, uh, VA bills that are in the house right now and Senate is, is putting together their version of these two bills, um, so that they can move in tandem with each other. Melissa Lavasani: I think that, you know, there's an opportunity here for. Us to show the federal government as an ecosystem, Hey, we, we are so much further ahead and you know, this is what we've organized and here's how we can help you, um, that would make them buy into this issue a bit more and potentially move things forward faster. Melissa Lavasani: Uh, at this point in time, it's, I think that, [00:28:00] you know, psychedelics aren't necessarily the taboo thing that they, they used to be, but there's certainly places that need attention. Um, there's certainly conversations that need to be had, and like I said, like PMC is just one organization that can do this. Um, we can certainly organize and drive forward collaboration, but I, like we alone, cannot cover all this ground and we need the subject matter experts to collaborate with us so we can, you know, once we get in the door, we wanna bring the experts in to talk to these officials about it. Melissa Lavasani: So I. I, I really want listeners to really think about us as a convener of sorts when it comes to federal policy. Um, and you know, I think when, like for example, in the early eighties, a lot of people have made comparisons to the issue of psychedelics to the issue of AIDS research and how you have in a subject matter that's like extremely taboo and a patient population that the government [00:29:00] quite honestly didn't really care about in the early eighties. Melissa Lavasani: But what they did as an ecosystem is really organized themselves, get very clear on what they wanted the federal government to do. And within a matter of a couple years, uh, AIDS research funding was a thing that was happening. And what that, what that did was that ripple effect turned that into basically finding new therapies for something that we thought was a death, death sentence before. Melissa Lavasani: So I think. We just need to look at things in the past that have been really successful, um, and, and try to take the lessons from all of these issues and, and move forward with psychedelics. Joe Moore: Love that. And yes, we always need to be figuring out efficient approaches and where it has been successful in the past is often, um, an opportunity to mimic and, and potentially improve on that. Melissa Lavasani: Yeah. Jay Kopelman: One, one thing I think it's important to add to this part of the conversation is that, [00:30:00] you know, Melissa pointed out there are a number of organizations that are essentially doing the same thing. Jay Kopelman: Um, you know, I like to think we do things a little bit differently at Mission within Foundation in that we don't target any one specific type of service member. We, we work with all veterans. We work with first responders, but. What that leads to is that there are, as far as I've seen, nothing but good intentioned people in this space. Jay Kopelman: You know, people who really care about their patient population, they care about healing, they are trying to do a good job, and more importantly, they're trying to do good. Right? It, it, I think they all see the benefit down the road that this has, [00:31:00] pardon me, not just for veterans, but for society as a whole. Jay Kopelman: And, and ultimately that's where I would like to see this go. You know, I, I would love to see the VA take this. Take up this mantle and, and run with it and provide great data, great outcomes. You know, we are doing some data collection ourselves at Mission within foundation, albeit anecdotal based on surveys given before and after retreats. Jay Kopelman: But we're also working with, uh, Greg Fonzo down at UT Austin on a brain study he's doing that will have 40 patients in it when it's all said and done. And I think we have two more guys to put through that. Uh, and then we'll hit the 40. So there, there's a lot of good here that's being done by some really, really good people who've been doing this for a long time [00:32:00] and want to want nothing more than to, to see this. Jay Kopelman: Come to, come full circle so that we can take care of many, many, many people. Um, you know, like I say, I, I wanna work myself out of a job here. I, I just, I would love to see this happen and then I, you know, I don't have to send guys to Mexico to do this. They can go to their local VA and get the care that they need. Jay Kopelman: Um, but one thing that I don't think we've touched on yet, or regarding that is that the VA isn't designed for that. So it's gonna be a pretty big lift to get the right types of providers into the va with the knowledge, right, with the institutional knowledge of how this should be done, what is safe, what is effective, um, and then it, it's not just providing these medicines to [00:33:00] people and sending them home. Jay Kopelman: You don't just do that, you've gotta have the right therapists on the backend who can provide the integration coaching to the folks who are receiving these medicines. And I'm not just talking, I bga, even with MDMA and psilocybin, you should have a proper period of integration. It helps you to understand how this is going to affect you, what it, what the experience really meant, you know, because it's very difficult sometimes to just interpret it on your own. Jay Kopelman: And so what the experience was and what it meant to you. And, and so it will take some time to spin all that up. But once it's, once it's in place, you know, the sky's the limit. I think. Joe Moore: Kinda curious Jay, about what's, what's going on with Ibogaine at the federal level. Is there anything at VA right now? [00:34:00] Jay Kopelman: At the va? No, not with ibogaine. And, you know, uh, we, we send people specifically for IBOGAINE and five MEO, right? And, and so that, that doesn't preclude my interest in seeing this legislation passed, right? Jay Kopelman: Because it, it will start with something like MDMA or psilocybin, but ultimately it could grow to iboga, right? It the think about the cost savings at, at the va, even with psilocybin, right? Where you could potentially treat somebody with a very inexpensive dose of psilocybin or, or iboga one time, and then you, you don't have to treat them again. Jay Kopelman: Now, if I were, uh, you know, a VA therapist who's not trained in psychedelic trauma therapy. I might be worried [00:35:00] about job security, but it's like with anything, right? Like ultimately it will open pathways for new people to get that training or the existing people to get that training and, and stay on and do that work. Jay Kopelman: Um, which only adds another arrow to their quiver as far as I'm concerned, because this is coming and we're gonna need the people. It's just like ai, right? Like ai, yeah. Some people are gonna lose some jobs initially, and that's unfortunate. But productivity ultimately across all industries will increase and new jobs will be created as a result of that. Jay Kopelman: I mean, I was watching Squawk Box one morning. They were talking about the AI revolution and how there's gonna be a need for 500,000 electricians to. Build these systems that are going to work with the AI [00:36:00] supercomputers and, and so, Joe Moore: mm-hmm. Jay Kopelman: Where, where an opportunity may be lost. I think several more can be gained going forward. Melissa Lavasani: And just to add on what Jay just said there, there's nothing specific going on with Ibogaine at, at the va, but I think this administration is, is taking a real look at addiction in particular. Uh, they just launched, uh, a new initiative, uh, that's really centered on addiction treatments called the Great American Recovery. Melissa Lavasani: And, um, they're dedicating a hundred million dollars towards treating addiction as like a chronic treatable disease and not necessarily a law enforcement issue. So, um, in that initiative there will be federal grant programs for prevention and treatment and recovery. And, um, while this isn't just for psychedelic medicines, uh, I think it's a really great opportunity for the discussion of psychedelics to get elevated to the White House. Melissa Lavasani: Um, [00:37:00] there's also, previous to this announcement last week from the White House, there's been a hundred million dollars that was dedicated at, um, at ARPA h, which is. The advanced research projects, uh, agency for healthcare, um, and that is kind of an agency that's really focused on forward looking, um, treatments and technologies, uh, for, um, a, a whole slew of. Melissa Lavasani: Of issues, but this a hundred million dollars is dedicated to mental health and addiction. So there's a lot of opportunity there as well. So we, while I think, you know, some people are talking about, oh, we need a executive order on Iboga, it's like, well, you know, the, the president is thinking, um, about, you know, what issues can land with his, uh, voting block. Melissa Lavasani: And I think it's, I don't think we necessarily need a specific executive order on Iboga to call this a success. It's like, let's look at what, [00:38:00] um, what's just been announced from the White House. They're, they're all in on. Thinking creatively and finding, uh, new solutions for this. And this is kind of, this aligns with, um, HHS secretaries, uh, Robert F. Melissa Lavasani: Kennedy Junior's goals when he took on this, this role of Health Secretary. Um, addiction has been a discussion that, you know, he has personal, um, a personal tie to from his own experience. And, um, I think when this administration started, there was so much like fervor around the, the dialogue of like, everyone's talking about psychedelics. Melissa Lavasani: It was Secretary Kennedy, it was, uh, secretary Collins at the va. It was FDA Commissioner Marty Macari. And I think that there's like a lot of undue frustration within folks 'cause um, you don't necessarily snap your fingers and change happens in Washington dc This is not the city for that. And it's intentionally designed to move slow so that we can avoid really big mistakes. Melissa Lavasani: Um. [00:39:00] I think we're a year into this administration and these two announcements are, are pretty huge considering, um, you know, the, we, there are known people within domestic policy council that don't, aren't necessarily supportive of psychedelic medicine. So there's a really amazing progress here, and frustrating as it might be to, um, just be waiting for this administration to make some major move. Melissa Lavasani: I think they are making major moves like for Washington, DC These, these are major moves and we just gotta figure out how we can, um, take these initiatives and apply them to the issue of psychedelic medicines. Joe Moore: Thanks, Melissa. Um, yeah, it is, it is interesting like the amount of fervor there was at the beginning. You know, we had, uh. Kind of one of my old lawyers, Matt Zorn, jumped in with the administration. Right. And, um, you know, it was, uh, really cool to [00:40:00] see and hopeful how much energy was going on. It's been a little quiet, kind of feels like a black box a little bit, but I, you know, there was, Melissa Lavasani: that's on me. Melissa Lavasani: Maybe I, we need to be more out in public about like, what's actually happening, because I feel like, like day in and day out, it's just been, you gotta just mm-hmm. Like have that constant beat with the government. Mm-hmm. And, um, it's, it's, it's not the photo ops on the hill, it's the conversations that you have. Melissa Lavasani: It's the dinner parties you go to, it's the fundraisers you attend, you know? Mm-hmm. That's why I, I kind of have to like toot my own horn with PCs. Like, we need to be present here at, at not only on the Hill, not only at the White House, but kind of in the ecosystem of Washington DC itself. There's, it's, there are like power players here. Melissa Lavasani: There are people that are connected that can get things done, like. I mean, the other last week we had a big snow storm. I walked over to my friend's house, um, to have like a little fire sesh with them and our kids, and his next door neighbor came over. He was a member of Congress. I talked about the VA bills, like [00:41:00] we're reaching out to his office now, um, to get them, um, up to speed and hopefully get their co-sponsorship for, uh, the two VA bills. Melissa Lavasani: So, I mean, it, the little conversations you have here are just as important as the big ones with the photo ops. So, um, it, it's, it's really like, you know, building up that momentum and, and finding that time where you can really strike and make something happen. Joe Moore: Mm-hmm. Yeah. Jay, anything to add there? Jay Kopelman: Yeah, I was just gonna say that, you know, I, I, I think the fervor is still there, right? Jay Kopelman: But real life happens. Melissa Lavasani: Yes, Jay Kopelman: yes. And gets in the way, right? So, Melissa Lavasani: yeah, Jay Kopelman: I, I can't imagine how many issues. Secretary Kennedy has every day much less the president. Like there's so many things that they are dealing with on a daily basis, right? It, we, we just have to work to be the squeaky wheel in, in the right way, right. Jay Kopelman: [00:42:00] With the, with the right information at the right time. Like just inundating one of these organizations with noise, it's then it be with Informa, it just becomes noise, right? It it, it doesn't help. So when we have things to say that are meaningful and impactful, we do, and Melissa does an amazing job of that. Jay Kopelman: But, you know, it, it takes time. You know, it's, you know, we're not, this is, this is like turning an aircraft carrier, not a ski boat. Melissa Lavasani: Yeah, Joe Moore: yeah, absolutely. Um, and. It's, it's understandably frustrating, I think for the public and the psychedelic public in particular because we see all this hope, you know, we continue to get frustrated at politics. It's nothing new, right? Um, and we, we wanna see more people get well immediately. [00:43:00] And I, I kind of, Jay from the veteran perspective, I do love the kind of loud voices like, you're making me go to Mexico for this. Joe Moore: I did that and you're making me leave the country for the thing that's gonna fix me. Like, no way. And barely a recognition that this is a valid treatment. You know, like, you know, that is complicated given how medicine is structured here domestically. But it's also, let's face the facts, like the drug war kind of prevented us from being able to do this research in the first place. Joe Moore: You know? Thanks Nixon. And like, how do we actually kind of correct course and say like, we need to spend appropriately on science here so we can heal our own people, including veterans and everybody really. It's a, it's a dire situation out there. Jay Kopelman: Yeah. It, it really is. Um, you know, we were talking briefly about addicts, right? Jay Kopelman: And you know, it's not sexy. People think of addicts as people who are weak-minded, [00:44:00] right? They don't have any self-control. Um, but, but look at, look at the opioid crisis, right? That Brian Hubbard was fighting against in Kentucky for all those years. That that was something that was given to the patient by a doctor that they then became dependent on, and a lot of people died from that. Jay Kopelman: And, and so you, you know, it's, I I don't think it's fair to just put all addicts in a box. Just like it's not fair to put all veterans in a box. Just like it's not fair for doctors, put all their patients in a box. We're individuals. We, we have individual needs. Our, our health is very individual. Like, I, I don't think I should be put in the same box as every other 66-year-old that my doctor sees. Jay Kopelman: It's not fair. [00:45:00] You know, if you, if you took my high school classmates and put us all in a photo, we're all gonna have different needs, right? Like, some look like they're 76, not 66. Some look like they're 56. Not like they're, we, we do things differently. We live our lives differently. And the same is true of addicts. Jay Kopelman: They come to addiction from different places. Not everybody decides they want to just try heroin at a party, and all of a sudden they're addicted. It happens in, in different ways, you know, and the whole fentanyl thing has been so daggum nefarious, right? You know, pushing fentanyl into marijuana. Jay Kopelman: Somebody's smoking a joint and all of a sudden they're addicted to fentanyl or they die. Melissa Lavasani: I think we're having a, Jay Kopelman: it's, it's just not fair to, to say everybody in this pot is the same, or everybody in this one is the same. We have [00:46:00] to look at it differently. Joe Moore: Yeah. I like to zoom one level out and kind of talk about, um, just how hurt we are as a country, as a world really, but as a country specifically, and how many people are out of work for so many. Joe Moore: Difficult reasons and away from their families for so many kind of tragic reasons. And if we can get people back to their families and back to work, a lot of these things start to self-correct, but we have to like have those interventions where we can heal folks and, and get them back. Um, yeah. And you know, everything from trauma, uh, in childhood, you know, adulthood, combat, whatever it is. Joe Moore: Like these things can put people on the sidelines. And Jay, to your point, like you get knee surgery and all of a sudden you're, you know, two years later you're on the hunt for Fentanyl daily. You know, that's tough. It's really tough. Carl Hart does a good job talking about this kind of addiction pipeline and [00:47:00] a few others do as well. Joe Moore: But it's just, you know, kind of putting it in a moral failure bucket. It's not great. I was chatting with somebody about, um, veterans, it's like you come back and you're like, what's gonna make me feel okay right now? And it's not always alcohol. Um, like this is the first thing that made me feel okay, because there's not great treatments and there's, there's a lot of improvements in this kind of like bringing people back from the field that needs to happen. Joe Moore: In my opinion. I, it seems to be shared by a lot of people, but yeah, there's, it's, it's, IGA is gonna be great. It's gonna be really important. I really can't wait for it to be at scale appropriately, but there's a lot of other things we need to fix too, um, so that we can just, you know, not have so many people we need to, you know, spend so much money healing. Joe Moore: Mm-hmm. Jay Kopelman: Yeah. You ahead with that. We don't need the president to sign an executive order to automatically legalize Ibogaine. Right. But it would be nice if he would reschedule it so that [00:48:00] then then researchers could do this research on a larger scale. You know, we could, we could now get some real data that would show the efficacy. Jay Kopelman: And it could be done in a safe environment, you know? And, and so that would be, do Joe Moore: you have any kind of figures, like, like, I've been talking about this for a while, Jay. Like, does it drop the cost a lot of doing research when we deschedule things? Jay Kopelman: I, I would imagine so, because it'll drop the cost of accessing the medicines that are being researched. Jay Kopelman: Right? You, you would have buy-in from more organizations. You know, you might even have a pharma company that comes into this, you know, look at j and j with the ketamine, right? They have, they have a nasal spray version of ketamine that's doing very well. I mean, it's probably their, their biggest revenue [00:49:00] provider for them right now. Jay Kopelman: And, and so. You know, you, it would certainly help and I think, I think it would lower costs of research to have something rescheduled rather than being schedule one. You know it, people are afraid to take chances when you're talking about Schedule one Melissa Lavasani: labs or they just don't have the money to research things that are on Schedule one. Melissa Lavasani: 'cause there's so much in an incredible amount of red tape that you have to go through and, and your facility has to be a certain way and how you contain those, uh, medicines. Oh, researching has to be in a specific container and it's just very cumbersome to research schedule one drugs. So absolutely the cost would go down. Melissa Lavasani: Um, but Joe Moore: yeah, absolutely. Less safes. Melissa Lavasani: Yeah. Joe Moore: Yes. Less uh, Melissa Lavasani: right. Joe Moore: Locked. Yeah. Um, it'll be really interesting when that happens. I'm gonna hold out faith. That we can see some [00:50:00] movement here. Um, because yeah, like why make healing more expensive than it needs to be? I think like that's potentially a protectionist move. Joe Moore: Like, I'm not, I'm not here yet, but, um, look at AbbVie's, uh, acquisition of the Gilgamesh ip. Mm-hmm. Like that's a really interesting move. I think it was $1.2 billion. Mm-hmm. So they're gonna wanna protect that investment. Um, and it's likely going to be an approved medication. Like, I don't, I don't see a world in which it's not an approved medication. Joe Moore: Um, you know, I don't know a timeline, I would say Jay Kopelman: yeah. Joe Moore: Less than six years, just given how much cash they've got. But who knows, like, I haven't followed it too closely. So, and that's an I bga derivative to be clear, everybody, um mm-hmm. If you're not, um, in, in the loop on that, which is hopeful, you know? Joe Moore: Mm-hmm. But I don't know what the efficacy is gonna be with that compared to Ibogaine and then we have to talk about the kind of proprietary molecule stuff. Um, there's like a whole bunch of things that are gonna go on here, and this is one of the reasons why I'm excited about. Federal involvement [00:51:00] because we might actually be able to have some sort of centralized manufacturer, um, or at least the VA could license three or four generic manufacturers per for instance, and that way prices aren't gonna be, you know, eight grand a dose or whatever. Joe Moore: You know, it's, Jay Kopelman: well, I think it's a very exciting time in the space. You know, I, I think that there's the opportunity for innovation. There is the opportunity for collaboration. There's the opportunity for, you know, long-term healing at a very low cost. You know, that we, we have the highest healthcare cost per capita in the world right here in the us. Jay Kopelman: And, and yet we are not the number one health system in the world. So to me, that doesn't add up. So we need to figure out a way to start. Bringing costs down for a lot of people and [00:52:00] at the same time increasing, increasing outcomes. Joe Moore: Absolutely. Yeah. There's a lot of possible outcome improvements here and, and you know, everything from relapse rates, like we hear often about people leaving a clinic and they go and overdose when they get home. Tragically, too common. I think there's everything from, you know, I'm Jay, I'm involved in an organization called the Psychedelics and Pain Association. Joe Moore: We look at chronic pain very seriously, and IGA is something we are really interested in. And if. We could have better, you know, research, there better outcome measures there. Um, you know, perhaps we can have less people on opioids to begin with from chronic pain conditions. Um, Jay Kopelman: yeah, I, I might be due for another Ibogaine journey then, because I deal with chronic pain from Jiujitsu, but, Joe Moore: oh gosh, let's Jay Kopelman: talk Joe Moore: later. Jay Kopelman: That's self inflicted. Some people would say take a month off, but Melissa Lavasani: yeah, Jay Kopelman: I'm [00:53:00] not, I'm not that smart. Joe Moore: Yeah. Um, but you know, this, uh, yeah, this whole thing is gonna be really interesting to see how it plays out. I'm endlessly hopeful pull because I'm still here. Right. I, I've been at this for almost 10 years now, very publicly, and I think we are seeing a lot of movement. Joe Moore: It's not always what we actually wanna see, but it is movement nonetheless. You know, how many people are writing on this now than there were before? Right. You know, we, we have people in New York Times writing somewhat regularly about psychedelics and. Even international media is covering it. What do we have legalization in Australia somewhat recently for psilocybin and MDMA, Czech Republic. Joe Moore: I think Germany made some moves recently. Mm-hmm. Um, really interesting to see how this is gonna just keep shifting. Um Jay Kopelman: mm-hmm. Joe Moore: And I think there's no way that we're not gonna have prescription psychedelics in three years in the United States. It pro probably more like a [00:54:00] year and a half. I don't know. Do you, are you all taking odds? Melissa Lavasani: Yeah. I mean, I think Jay Kopelman: I, I gotta check Cal sheet, see what they're saying. Melissa Lavasani: I think it's safe to say, I mean, this could even come potentially the end of this year, I think, but definitely by the end of 2027, there's gonna be at least one psychedelic that's FDA approved. Joe Moore: Yeah. Yeah. Melissa Lavasani: If you're not counting Ketamine. Joe Moore: Right. Jay Kopelman: I, I mean, I mean it mm-hmm. It, it doesn't make sense that it. Shouldn't be or wouldn't be. Right. The, we've seen the benefits. Mm-hmm. We know what they are. It's at a very low cost, but you have to keep in mind that these things, they need to be done with the right set setting and container. Right. And, and gotta be able to provide that environment. Jay Kopelman: So, but I would, I would love, like I said, I'd love to work myself out of a job here and see this happen, not just for our veterans, [00:55:00] but for everybody. Joe Moore: Mm-hmm. Um, so Melissa, is there a way people can get involved or follow PMC or how can they support your work at PMC? Melissa Lavasani: Yeah, I mean, follow us in social media. Melissa Lavasani: Um, our two biggest platforms are LinkedIn and Instagram. Um, I'm bringing my newsletter back because I'm realizing, um, you know, there is a big gap in, in kind of like the knowledge of Washington DC just in general. What's happening here, and I think, you know, part of PC's value is that we're, we are plugged into conversations that are being had, um, here in the city. Melissa Lavasani: And, you know, we do get a little insight. Um, and I think that that would really quiet a lot of, you know, the, a lot of noise that, um, exists in the, our ecosystem. If, if people just had some clarity on like, what's actually happening or happening here and what are the opportunities and, [00:56:00] um, where do we need more reinforcement? Melissa Lavasani: Um, and, and also, you know, as we're putting together public education campaign, you know. My, like, if I could get everything I wanted like that, that campaign would be this like multi-stakeholder collaborative effort, right? Where we're covering all the ground that we need to cover. We're talking to the patient groups, we're talking to traditional mental health organizations, we're talking to the medical community, we're talking to the general population. Melissa Lavasani: I think that's like another area that we, we just seem to be, um, lacking some effort in. And, you know, ultimately the veteran story's always super compelling. It pulls on your heartstrings. These are our heroes, um, of our country. Like that, that is, that is meaningful. But a lot of the veteran population is small and we need the, like a, the just.[00:57:00] Melissa Lavasani: Basic American living in middle America, um, understanding what psychedelics are so that in, in, in presenting to them the stories that they can relate to, um, because that's how you activate the public and you activate the public and you get them to see what's happening in these clinical trials, what the data's been saying, what the opportunities are with psychedelics, and then they start calling their members of Congress and saying, Hey, there is this. Melissa Lavasani: Bill sitting in Congress and why haven't you signed onto it? And that political pressure, uh, when used the right way can be really powerful. So, um, I think, you know, now we're at this really amazing moment where we have a good amount of congressional offices that are familiar enough with psychedelics that they're willing to move on it. Melissa Lavasani: Um, there's another larger group, uh, that is familiar with psychedelics and will assist and co-sponsor legislation, but there's still so many offices that we haven't been able to get to just 'cause like we don't have all the time in the world and all the manpower in the world to [00:58:00] do it. But, you know, that is one avenue is like the advocates can speak to the, the lawmakers, the experts speak to the lawmakers, and we not, we want the public engaged in this, you know, ultimately, like that's. Melissa Lavasani: Like the best form of harm reduction is having an informed public. So we are not, they're not seeing these media headlines of like, oh, this miracle cure that, um, saved my family. It's like, yes, that can happen psychedelics. I mean, person speaking personally, psychedelics did save my family. But what you miss out of that story is the incredible amount of work I put into myself and put into my mental health to this day to maintain, um, like myself, my, my own agency and like be the parent that I wanna be and be the spouse that I wanna be. Melissa Lavasani: So, um, we, we need to continue to share these stories and we need to continue to collaborate to get this message out because we're all, we're all in the same boat right now. We all want the same things. We want patients to have safe and [00:59:00] affordable access to psychedelic assisted care. Um, and, uh. We're just in the beginning here, so, um, sign up for our newsletter and we can sign up on our website and then follow us on social media. Melissa Lavasani: And, um, I anticipate more and more events, um, happening with PMC and hopefully we can scale up some of these events to be much more public facing, um, as this issue grows. So, um, I'm really excited about the future and I'm, I've been enjoying this partnership with Mission Within. Jay is such a professional and, and it really shows up when he needs to show up and, um, I look forward to more of that in the future. Joe Moore: Fantastic. And Jay, how can people follow along and support mission within Foundation? Jay Kopelman: Yeah, again, social media is gonna be a good way to do that. So we, we are also pretty heavily engaged on LinkedIn and on Instagram. Um, I do [01:00:00] share, uh, a bit of my own stuff as well. On social media. So we have social media pages for Mission within Foundation, and we have a LinkedIn page for mission within foundation. Jay Kopelman: I have my own profiles on both of those as well where people can follow along. Um, one of the other things you know that would probably help get more attention for this is if the general public was more aware of the numbers of professional athletes who are also now pursuing. I began specifically to help treat their traumatic brain injuries and the chronic traumatic encephalopathy that they've, uh, suffered as a result of their time in professional sports or even college sports. Jay Kopelman: And, you know. I people worship these athletes, and I [01:01:00] think that if more of them, like Robert Gall, were more outspoken about these treatments and the healing properties that they've provided them, that it would get even more attention. Um, I think though what Melissa said, you know, I don't wanna parrot anything she just said because she said it perfectly Right. Jay Kopelman: And I'd just be speaking to hear myself talk. Um, but being collaborative the way that we are with PMC and with Melissa is I think, the way to move the needle on this overall. And like she said, if she could get more groups involved in, in these discussions, it would, it would do wonders for us. Joe Moore: Well, thank you both so much for your hard work out there. I always appreciate it when people are showing up and doing this important, [01:02:00] sometimes boring and tedious, but nevertheless sometimes, sometimes exciting work. And um, so yeah, just thank you both and thank you both for showing up here to psychedelics today to join us and I hope we can continue to support you all in the future. Jay Kopelman: Thank you, Joe. Thank you, Joe. It's a pleasure being with you today and with Melissa, of course, always Melissa Lavasani: appreciate the time and space. Joe Moore: Thanks.
Few issues have tested public trust in medicine as deeply as vaccines, and few individuals have influenced that dialogue more than Dr. Paul Offit, director of the Vaccine Education Center at the Children's Hospital of Philadelphia and a longtime member of the FDA's Vaccine Advisory Committee. In this timely and candid interview with Raise the Line host Lindsey Smith, Dr. Offit points to this year's severe flu season and a resurgence of measles as alarming proof points of how a changing federal perspective on vaccine policy is having a real impact on public health. “You'd like to think you can educate about the importance of vaccines, but I fear at this point the viruses themselves are doing the educating.” In this wide ranging discussion, Dr. Offit also addresses: The rigorous and painstaking process of developing vaccines, based on his experience co-inventing the rotavirus vaccine. Shifting levels of public trust in scientific organizations. Promising innovations in vaccine development. Don't miss this deeply-informed perspective on the interplay of science, policy, and public education, and his encouraging message to young clinicians about managing the current challenges in public health. Mentioned in this episode: Vaccine Education Center at Children's Hospital of PhiladelphiaPerelman School of Medicine If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast
Part two of our conversation with John Barnas, Executive Director at the Michigan Center for Rural Health. We continue our discussion on how rural healthcare professionals and organizations can prepare their states for the impact of funding cuts at the federal level. We'll talk about the Rural Health Transformation Fund, how to navigate HHS and CMS guidelines and of course, what it all has to do with rural health. Follow Rural Health Today on social media! https://x.com/RuralHealthPod https://www.youtube.com/@ruralhealthtoday7665 Follow Hillsdale Hospital on social media! https://www.facebook.com/hillsdalehospital/ https://www.twitter.com/hillsdalehosp/ https://www.linkedin.com/company/hillsdale-community-health-center/ https://www.instagram.com/hillsdalehospital/ Follow John Barnas on social media! https://www.linkedin.com/in/john-barnas-a7519115/ Follow the Michigan Center for Rural Health on social media! https://www.facebook.com/MCRH91/
In 2026, the landscape of digital privacy in healthcare has shifted dramatically. It's no longer just about staying HIPAA compliant; it's about navigating a "wild west" of state-level consumer data laws, aggressive class-action lawsuits, and the end of surveillance-based marketing.In this first of a two-part series, Jennifer and Corey break down why your standard Google Analytics setup might actually be a liability and how 20 different state regulatory environments are changing the rules for healthcare marketers. We discuss the rise of a new cottage industry of privacy litigation and why "Accept Cookies" banners are no longer enough to protect your practice.Key Takeaways:The New Privacy Landscape: Why privacy is becoming a standalone regulatory category separate from HIPAA.The Google Analytics Problem: Understanding why HHS and OCR guidance suggests that tools like Google Analytics can create PHI violations simply by tracking IP addresses on condition pages.State-Specific Hazards: A look at the strict laws already on the books in Washington, Nevada, Connecticut, and Maryland.The Ambulance Chasers of Tech: How law firms are targeting practices for pixel-related tracking violations.Trust as a Commodity: Why protecting patient data from big tech is now a brand differentiator and a way to build long-term patient loyalty.
In episode 2008, Jack and Miles are joined by comedian, Blake Wexler, to discuss… WHITE CULTURE Taking Ls, Obama Walks Back Claim That Aliens Are Real, RFK Jr. Compared COVID To Snorting Coke Off Of Toilet Seats, Melania Watch and more! WHITE CULTURE Taking Ls Obama: "Yes aliens are real." Interviewer: "Haha. OK, let's move onto the next topic." Obama clarifies comments on aliens being real, says he saw 'no evidence' they've made contact The Secret's Out: Obama Acknowledges Existence Of Area 51 RFK Jr: I'm not afraid of a germ. I used to snort cocaine off of toilet seats. RFK Jr. — America's Health Secretary — Told Theo Von He Used to Snort Cocaine Off Toilet Seats, Then Laughed at a Vaccine Joke LISTEN: Hide No Signs by Dusty BrownSee omnystudio.com/listener for privacy information.
The alleged affair between DHS Sec. Kristi Noem and her advisor Corey Lewandowski is reportedly making life hell for their staffers, President Obama backpedaled after telling a podcaster that aliens are real, and you should think twice before taking nutrition advice from the chatbot on the new HHS website. Beloved actress Jennifer Garner knows how to live life to the fullest, whether it's taking her mom to Canada to see the Northern Lights, or enjoying the unique pleasures of a snow day in New York City. Watch the Season Two premiere of “The Last Thing He Told Me” this Friday on AppleTV. To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices
Health Affairs' Jeff Byers welcomes Georgetown University's Katie Keith back to the podcast to break down the newly proposed HHS rule that could bring major changes to the ACA beginning in 2027.They discuss the proposal's biggest shifts, including a major push toward expanding catastrophic plans, new marketplace eligibility restrictions tied to the One Big Beautiful Bill Act, and potential impacts on premiums, marketplace enrollment, insurers, and consumers.Related Links:HHS Proposes Sweeping Changes for 2027 Marketplace Plans (Part 1) (Health Affairs Forefront)HHS Proposes Sweeping Changes for 2027 Marketplace Plans (Part 2) (Health Affairs Forefront)Trump Team's Planned ACA Rule Offers Its Answer to Rising Premium Costs: Catastrophic Coverage (KFF Health News)CMS proposes sweeping ACA exchange rule (Healthcare Dive)
This week on the Queer News podcast, In top news, The Trump Administration ordered the removal of the pride flag from Stonewall. Cathy Renna was there in person and left us a voicemail to share more about it. In politics, The Trump Administration attempts to revoke $600 million in health care funding from four states who've vocally opposed him, and we break down what the Transgender Bill Of Rights could look like. In culture and entertainment, Don Lemon pleads not guilty to federal charges and the Seeing Her docu-series premieres! Let's get into it. Want to support this podcast?
Dr. Andrew Whitehead joins Brad Onishi to discuss his groundbreaking research revealing a disturbing connection: Christian nationalism is one of the strongest predictors of discrimination against Americans with disabilities. As the Trump administration slashes protections, funding, and civil rights for disabled people, from dismantling DEIA efforts to appointing RFK Jr. to HHS, this conversation exposes the theological and ideological roots of ableism in the Christian nationalist movement. Whitehead's peer-reviewed research shows that those who embrace Christian nationalism are three times more likely to believe we've "done enough" for people with disabilities and twice as likely to say disabled Americans "demand too much." The discussion traces these attitudes through Project 2025, prosperity gospel theology, and the historical fusion of Christian nationalism with free-market capitalism that elevates economic productivity as the measure of human worth. This episode challenges listeners to confront how certain strains of Christianity have interpreted disability as divine punishment or an opportunity for charity, rather than recognizing structural barriers that demand collective responsibility. From religious school vouchers that exclude disabled students to the dangerous myth that autism is spreading like a disease, Whitehead and Onishi reveal how the imagined "ideal American body" in Christian nationalist ideology is explicitly straight, white, native-born, and able-bodied. The conversation offers a powerful counter-vision through theologians like Nancy Eiesland, who reimagined God as disabled, and calls for Christians to vote for policies that truly value all people, not just prayers, but action. Subscribe for $3.65: https://axismundi.supercast.com/ Subscribe to our free newsletter: https://swaj.substack.com/ Order American Caesar by Brad Onishi: https://static.macmillan.com/static/essentials/american-caesar-9781250427922/Linktree: https://linktr.ee/StraightWhiteJC Donate to SWAJ: https://axismundi.supercast.com/donations/new Learn more about your ad choices. Visit megaphone.fm/adchoices
Your weekly report from Abobolandia is here, it's hot, and it's served up fresh with a heavy dollop of snark. The attacks on the abortion pill mifepristone continue. HHS just said pharmacies don't have to stock abortion pills anymore. Cool cool cool. Totally normal functioning democracy stuff.Meanwhile, manufacturers of the pill are gearing up to fight what could become a national telehealth abortion ban, and for once we're actually rooting for Big Pharma. We won't make it a thing, we promise. GUEST ROLL CALL:Moji and Lizz sit down with Amy Hagstrom Miller, President & CEO of Whole Woman's Health, who is providing telehealth abortion care in 10 states while the federal government plays regulatory roulette with people's bodies. Independent clinics still provide the majority of abortion care in this country. Yes, indie clinics, not hospital systems, not corporations, and they are being squeezed from every direction. Then musician and activist Gwen Levey pulls up to talk to Moji about using her voice loudly in a moment when silence is complicity, and especially as the DOJ refuses to meaningfully pursue accountability for the victims of Jeffrey Epstein. Her video, “Barefoot & Pregnant,” recently went viral for highlighting the atrocities of Project 2026. Institutions bending over backwards for predators and cracking down on bodily autonomy is all part of their plan. But never, fear! We have the info you need and the tools to fight back.Times are heavy, but knowledge is power, y'all. We gotchu. OPERATION SAVE ABORTION: You can still join the 10,000+ womb warriors fighting the patriarchy by clicking HERE to for past Operation Save Abortion trainings, your toolkit, marching orders, and more.HOSTS:Lizz Winstead IG: @LizzWinstead Bluesky: @LizzWinstead.bsky.socialMoji Alawode-El IG: @Mojilocks Bluesky: @Mojilocks.bsky.socialSPECIAL GUESTS:Amy Hagstrom Miller IG: @wholewomans @wwhallianceGwen Levey IG: @gwenleveymusic @riseabovejusticemovementGUEST LINKS:Whole Woman's HealthWhole Woman's Health Virtual ServicesWhole Woman's Health Alliance LinktreeDONATE: Whole Woman's HealthDONATE: Whole Woman's Health Alliance Gwen Levey Linktree“Barefoot & Pregnant” Exposes Project 2026 in Viral VideoRise Above Justice Movement WebsiteRise Above Justice Movement LinktreeRise Above Justice Movement PodcastNEWS DUMP:HHS Will Allow Pharmacies to Boycott Lifesaving Drugs Used in Medication AbortionMifepristone Manufacturers Move to Block GOP Lawsuit Seeking Nationwide Telehealth Abortion BanIndependent Clinics Still Provide Most U.S. AbortionsEPISODE LINKS:TICKETS: Michael Shannon & Jason Narducy TourBUY: Michael Shannon & Jason Naruducy 2026 Tour PosterADOPT-A-CLINIC: Whole Woman's Health of MinnesotaOperation Save AbortionExpose Fake ClinicsBUY AAF MERCH!EMAIL your abobo questions to The Feminist BuzzkillsAAF's Abortion-Themed Rage PlaylistFOLLOW US:Listen to us ~ FBK Podcast Instagram ~ @AbortionFrontBluesky ~ @AbortionFrontTikTok ~ @AbortionFrontFacebook ~ @AbortionFrontYouTube ~ @AbortionAccessFrontTALK TO THE CHARLEY BOT FOR ABOBO OPTIONS & RESOURCES HERE!PATREON HERE! Support our work, get exclusive merch and more! DONATE TO AAF HERE!ACTIVIST CALENDAR HERE!VOLUNTEER WITH US HERE!ADOPT-A-CLINIC HERE!GET ABOBO PILLS FROM PLAN C PILLS HERE!When BS is poppin', we pop off! Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Robert F. Kennedy Jr. is the United States Secretary of Health and Human Services. Before this he was a presidential candidate, attorney and environmentalist. RFK Jr. joins Theo to talk about going from an outsider to the head of HHS, how much fraud he uncovered in existing government agencies, and the research that went into developing the new food pyramid. Robert F. Kennedy Jr.: https://www.instagram.com/robertfkennedyjr/ ------------------------------------------------ Tour Dates! https://theovon.com/tour New Merch: https://www.theovonstore.com ------------------------------------------------- Sponsored By: Celsius: Go to the Celsius Amazon store to check out all of their flavors. #CELSIUSBrandPartner #CELSIUSLiveFit https://amzn.to/3HbAtPJ Moonpay: Head over to https://www.moonpay.com/theo to sign up Tecovas: Go to http://tecovas.com/theo for 10% off. Ethos: Protect your family with life insurance from Ethos. Get up to $3 million in coverage in as little as 10 minutes at https://ethos.com/THEO. Application times may vary. Rates may vary. Morgan and Morgan: Visit https://forthepeople.com/THEO to see if you might have a case. Morgan and Morgan. America's Largest Injury Law Firm. Ryl Tea: the tea that cleaned up its act and still tastes like the good old days. Refresh yourself now at www.drinkryl.com ------------------------------------------------- Music: “Shine” by Bishop Gunn Bishop Gunn - Shine ------------------------------------------------ Submit your funny videos, TikToks, questions and topics you'd like to hear on the podcast to: tpwproducer@gmail.com Hit the Hotline: 985-664-9503 Video Hotline for Theo Upload here: https://www.theovon.com/fan-upload Send mail to: This Past Weekend 1906 Glen Echo Rd PO Box #159359 Nashville, TN 37215 ------------------------------------------------ Find Theo: Website: https://theovon.com Instagram: https://instagram.com/theovon Facebook: https://facebook.com/theovon Facebook Group: https://www.facebook.com/groups/thispastweekend Twitter: https://twitter.com/theovon YouTube: https://youtube.com/theovon Clips Channel: https://www.youtube.com/c/TheoVonClips Shorts Channel: https://bit.ly/3ClUj8z ------------------------------------------------ Producer: Zach https://www.instagram.com/zachdpowers Producer: Trevyn https://www.instagram.com/trevyn.s/ Producer: Nick https://www.instagram.com/realnickdavis/ Producer: Andrew https://www.instagram.com/bleachmediaofficial/ Producer: Halston https://www.instagram.com/halstonrays/ Learn more about your ad choices. Visit megaphone.fm/adchoices
Tara breaks down the explosive Super Bowl halftime fallout: nine million viewers tuned out, TPUSA streams spiked, and Bad Bunny's performance skirted FCC rules with explicit lyrics in Spanish. She digs into fines, legal accountability, and the history of broadcast censorship—from The Rolling Stones to modern NFL controversies. The episode also exposes shocking stories from sanctuary cities, including unaccompanied minors being placed with dangerous sponsors and the lack of follow-up on 65,000 emergency calls. Tara contrasts selective outrage over a January 6 pardoned defendant now convicted of child molestation with systemic failures in Democrat-run cities and federal oversight. She closes by examining political messaging failures, midterm implications, and how well-funded activist networks influence protests and riots. ⚡ PRIMARY TALKING POINTS Super Bowl halftime: 9M viewers walked out, TPUSA hits 26M streams Bad Bunny controversy: explicit lyrics, FCC fines, broadcast hypocrisy Historical censorship: Rolling Stones on Ed Sullivan vs. modern TV standards Sanctuary cities: minors placed with gang-affiliated sponsors, 65,000 unanswered emergency calls January 6 pardon fallout: convicted pedophile vs. media selective outrage Political messaging & midterms: mismanaged focus, NGO-funded activist networks, ICE policy battles
Tara dives into the biggest stories of the day: from the Super Bowl halftime shocker where nine million viewers walked out, to Bad Bunny's controversial performance skirting FCC fines, to the latest sanctuary city crises leaving children at risk. She dissects selective outrage over January 6 pardons, highlights NGO-funded activism, and exposes failures in political messaging and midterm strategies. This episode blends media critique, legal accountability, and political analysis with Tara's sharp, no-holds-barred commentary on how culture, law, and politics intersect in real time. ⚡ PRIMARY TALKING POINTS Super Bowl halftime: 9M viewers tuned out, TPUSA streams spike to 26M Bad Bunny controversy: explicit lyrics in Spanish, FCC implications, fines debate Historical censorship: Rolling Stones vs. modern NFL broadcasts Sanctuary cities & HHS: minors trafficked, 65,000 unanswered emergency calls January 6 pardons: convicted pedophile vs. media selective outrage Political messaging & midterms: NGO-funded activist networks, ICE policy battles, strategic failures
February 10, 2026: Your daily rundown of health and wellness news, in under 5 minutes. Today's top stories: Apple scraps AI-powered health coach project after delays, concluding it wasn't keeping pace with competitors like Oura, Whoop, and Ultrahuman Oura files patent for AR smart glasses displaying real-time health data controlled through ring-based gestures, positioning itself at center of ambient health tracking Hims & Hers pulls compounded oral GLP-1 pill amid regulatory pressure from HHS and FDA, with Novo Nordisk suing for patent infringement More from Fitt: Fitt Insider breaks down the convergence of fitness, wellness, and healthcare — and what it means for business, culture, and capital. Subscribe to our newsletter → insider.fitt.co/subscribe Work with our recruiting firm → https://talent.fitt.co/ Follow us on Instagram → https://www.instagram.com/fittinsider/ Follow us on LinkedIn → linkedin.com/company/fittinsider Reach out → insider@fitt.co
2. Minneapolis Situation & ICE Confrontations A. Escalating Conflict Recent fatal confrontations between civilians and ICE agents in Minneapolis. Two individuals (not known to be violent criminals) have been killed during encounters. Host urges toning down rhetoric from both political sides to prevent further escalation. B. Comparison Between Texas and Minnesota Texas sees far more ICE arrests but fewer violent confrontations. Reasons suggested: Texas law enforcement cooperates with ICE. Minnesota politicians (governor/mayor) allegedly encourage public confrontation with ICE. C. Violent Protest Structure Minneapolis protests are organized, funded, and operated similarly to military groups. Reports mentioned: Surveillance operations against law enforcement Protesters allegedly sabotaging vehicles and physically attacking officers Autonomous‑zone style barricades forming in some areas 3. Responsibility & Advice Regarding Police Encounters Do not escalate encounters with law enforcement. Entering a protest with a firearm greatly increases danger for everyone involved. Legal principles discussed: Lethal force is justified if officers reasonably believe there is a threat. Officers cannot shoot fleeing suspects unless they pose serious immediate danger. 4. Media Narratives & Political Messaging A. Suburban Women as Target Audience Democrats viewed as shaping narratives (e.g., “ICE shoots mother of three,” “ICE detains 5‑year‑old”) to emotionally influence suburban voters. Hosts argue some widely publicized stories were misleading or false. B. Claims of Political Motives Democrats are using these incidents to distract from: A major Minnesota fraud scandal involving billions of dollars. Each new confrontation diverts media attention from that scandal. 5. Anticipated Government Shutdown A. Democrat Position Multiple Democratic leaders publicly oppose funding DHS/ICE at current levels. Statements from Senators (Schumer, Warren, Murphy) emphasize refusal to pass DHS funding bill without ICE restrictions. B. Hosts’ Conclusion They expect a government shutdown, driven by attempts to: Defund or weaken ICE Appeal to progressive voters Control political narrative ahead of elections Shutdown would affect agencies not yet funded (e.g., Defense, Labor, Education, HHS, HUD, DHS). Please Hit Subscribe to this podcast Right Now. Also Please Subscribe to the 47 Morning Update with Ben Ferguson and The Ben Ferguson Show Podcast Wherever You get You're Podcasts. And don't forget to follow the show on Social Media so you never miss a moment! Thanks for Listening YouTube: https://www.youtube.com/@VerdictwithTedCruz/ Facebook: https://www.facebook.com/verdictwithtedcruz X: https://x.com/tedcruz X: https://x.com/benfergusonshowYouTube: https://www.youtube.com/@VerdictwithTedCruzSee omnystudio.com/listener for privacy information.